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Abstract 
 The structure and functional relationship between the melanocortin-2 receptor 
(MC2R) and adrenocorticotropic hormone (ACTH) is the most complex of the 
melanocortin gene family. Prior studies had been done on amniote tetrapod MC2Rs (e.g., 
mammals); this study analyzed the expression and activation of MC2R by an anamniote 
tetrapod, Xenopus tropicalis (xtMC2R). An immunofluorescence approach, done on the 
expression of xtMC2R in  Chinese Hamster Ovary cells (CHO cells), indicated that the 
trafficking of xtMC2R to the plasma membrane required co-expression with a tetrapod 
MRAP1(melanocortin-1 receptor accessory protein).   A cAMP-reporter assay was used 
to show that xtMC2R can activated by human ACTH(1-24, but not by  α-MSH. These 
two properties are also observed for human MC2R, and are common for tetrapod MC2Rs 
in general. Alanine-substitution analogs of hACTH(1-24) were used to deduce a possible 
mechanism for the activation of xtMC2R. These studies showed that alanine substitutions 
to the HFRW motif in hACTH(1-24) eliminated activation of the receptor. Furthermore, 
the alanine-substitution analysis revealed that positions 15 and 16 in the KKRRP motif 
are more important for the activation of xtMC2R than positions, 17 through 19. Finally, 
the alanine-substitution assays coupled with analysis of internally truncated analogs of 
the GKPVG motif resulted in decreased or complete elimination of xtMC2R activation. 
These data were used to construct a proposed three step model for the activation of 
 iii 
MC2R. The final goal of this thesis was to identify the region of the receptor involved in 
the docking of the KKRRP motif of ACTH. Based on a model of MC2R, these 
experiments used alanine substitution site-directed mutagenesis to analyze the 
transmembrane 4 (TM4), extracellular loop 2 (EL2), and transmembrane 5 (TM5) region 
of xtMC2R.  These experiments revealed that the following mutations had the greatest 
effect on the sensitivity (EC50 value) of xtMC2R:  I/A
175
, F/A
178
, and I/A
184
.  These 
results were compared to site-directed mutagenesis studies done on human and rainbow 
trout MC2Rs. Collectively, these analyses revealed that all three MC2Rs have docking 
sites for the KKRRP motif of ACTH that are similar in general location, and mostly 
similar in 3-dimensional structure, but that are not identical. The evolutionary 
implications of these observations are discussed.  
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Introduction 
Melanocortin Receptor Family: G-Coupled Protein Receptors 
The melanocortin receptors (MCRs) are a family of hormone-activated receptors 
that influence a number of physiological functions in mammals. The melanocortin 
receptor family consists of five different receptors, which were named in the numerical 
order in which they were cloned from the human genome (Cone, 2006). More so, each of 
these receptors is regulated by its own gene, and these receptors are expressed in different 
cells and tissues (Cone, 2006) throughout an organism. Melanocortin receptors are G 
protein-coupled receptors (GCPRs) that belong to the rhodopsin/β2-adrenergic-like family 
of GPCRs. G protein-coupled receptors are the largest group of cell surface receptors, 
and all these receptors use guanine nucleotide-binding proteins (G proteins) as 
transducers. All GCPRs have seven transmembrane domains that are linked by 
extracellular and intracellular protein loops. More specifically, the extracellular domains 
allow for the binding of specific ligands, which causes a conformational change in the 
receptor. In turn, this conformational change causes the intracellular G protein to be 
activated. Finally, a subunit of the G protein interacts with either an ion channel or an 
enzyme to illicit a biological response in the target cell. In the case of the melanocortin 
receptors the enzyme that is activated is adenylyl cyclase, and this enzyme generates the 
second messenger cyclic AMP (cAMP). The increase in the intracellular concentration of 
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cAMP results in the activation of protein kinase A, and this enzyme in turn, can activate 
transcription factors, interact with channels, or affect the activity of enzymes. The end 
result is a biological response within a cell (Cooper & Hausman, 2009).  
The MCRs appear to be the smallest GCPRs in terms of amino acid length, and 
have relatively short N- and C- terminal ends (Cooray & Clark, 2011). In terms of the 
location and function of the melanocortin receptors (Figure 1; Cone, 2006), MC1R is 
located on melanocytes, in areas of the brain, and on macrophages. This MCR plays a 
role in pigmentation (melanocytes), body temperature regulation (CNS), and has anti-
inflammatory properties. MC3R is predominantly expressed in the brain, but can be 
found in the placenta, stomach and pancreas; its main function lies in energy metabolism. 
MC4R is expressed mainly in the brain, as well as the autonomic nervous system, and 
spinal cord where it plays a role in the regulation of food consumption and energy output. 
MC5R is expressed in many different tissues including skin, adrenal and exocrine glands. 
It is thought to play a role in the production of types of lipids, as well as some regulation 
of the immune system. Finally, MC2R is located in the adrenal cortex, and is involved in 
the initiation of steroidogenesis; the production of the glucocorticoid, cortisol. However, 
this receptor is also expressed the in the skin (melanocytes), as well as, in adipocytes. 
MC2R is unlike any of the other melanocortin receptors because of its unique 
intracellular trafficking properties and ligand selectivity. 
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Figure 1: Melanocortin Receptor Expression, Function, and Ligand Selectivity 
(Figure adapted from Cone, 2006) 
 
Melanocortin Peptides Derived from Proopiomelanocortin 
The melanocortin receptors are activated by hormones derived from the 
proopiomelanocortin (POMC) gene, which is a member of the opioid/orphanin gene 
family (Dores & Baron, 2010). This gene is expressed in the pituitary gland, and is 
responsible for the production of POMC proproteins in two different types of pituitary 
cells: corticotropic and melanotropic cells. Located at the anterior pituitary, the 
corticotropic cells are responsible for the production of the hormone, adrenocorticotropin 
(ACTH), by the specific and selective posttranslational cleavage involving proprotein 
convertase 1/3 (PC 1/3) (Cone, 2006). At the intermediate pituitary, the melanotropic 
cells produce various hormones including:  γ-MSH, α-MSH, CLIP, β-MSH, and β-
endorphin by posttranslational events involving PC1/3, as well as, PC2 (Dores & Baron, 
2010). An illustration of these specific endoproteolytic cleavage events can be seen in 
Figure 2.  
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Figure 2: Illustration of POMC Post-Translational Cleavage Products 
 
(Figure adapted from Cone, 2006) 
 
A striking feature with respect to the evolution of the POMC gene is the 
remarkable degree of conservation in the organization of the precursor and the number of 
melanocortin-related sequences in organisms ranging from the jawless fishes to mammals 
as illustrated in Figure 3 (Vallarino et al., 2012).   
        Note also that α-MSH is the first 13 amino acids of ACTH (Figure 4). These 
peptides have the HFRW motif which is an essential feature of melanocortin-related 
peptides (Schwyzer, 1977). β-MSH and γ-MSH are located at completely different 
cleavage sites within POMC. These polypeptides share the HFRW motif with ACTH and 
alpha-MSH as well. 
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Figure 3: POMC Gene Phylogenic Tree 
 
(Vallarino et. al, 2012) 
 
Figure 4: Human & Xenopus tropicalis POMC Sequence and Peptides 
A) Vertebrate POMC Sequences 
Human POMC:  
MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRACKPDLSAETPMFPGNG
DEQPLTENPRKYVMGHFRWDRFGRRNSSSSGSSGAGQKREDVSAGEDCGPLPEGGPEPRSDGAKP
GPREGKRSYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEPKRELTGQRLREGDGPDGPA
DDGAGAQADLEHSLLVAAEKKDEGPYRMEHFRWGSPPKDKRYGGFMTSEKSQTPLVTLFKNAIIK
NAYKKGE 
Xenopus tropicalis POMC:  
MFRPLWGCSLAILGAFIFHVGEVQGQCWESSRCADLSSEDGVLECIKACKMDLSAESPVFPGNGH
LQPLSESIRKYVMTHFRWNKFGRRNSTGNDGSSSGYKREDISNYPVFNLFPVSDNMEQNAQGDNM
EGEPLDRQENKRAYSMEHFRWGKPVGRKRRPIKVYPNGVEEESSENYPMELRRELSLELDYPDID
LDEDIEDNEVESALTKKNGNYRMHHFRWGSPPKDKRYGGFMTPERSQTPLMTLFKNAIIKNTHKK
GQ 
Alpha-MSH 
ACTH 
Beta-MSH 
Gamma-MSH 
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B) Alignment of Conserved HFRW Domain for X. Tropicalis POMC Melanocortin Peptides 
                     10        20        30        40        
            ....|....|....|....|....|....|....|....|. 
alpha-MSH   --AYSMEHFRWGKPV--------------------------  
ACTH(1-39)  --AYSMEHFRWGKPVGRKRRPIKVYPNGVEEESSENYPMEL  
beta-MSH    NGNYRMHHFRWGSPPKD------------------------  
gamma-MSH   --KYVMTHFRWNKF---------------------------  
 
As shown in Figure 1, the MCRs can be activated by different peptide hormones 
derived from POMC. Based on studies on mammals, the MC1R, MC4R, and MC5R, all 
have a higher affinity for α-MSH, than ACTH, β-MSH, or γ-MSH, while MC3R interacts 
with γ-MSH, α-MSH, β-MSH, and ACTH with equal favorability. Although these 
different receptors seem to prefer one hormone or ligand over the other melanocortin 
peptides, they all respond to ACTH in varying degrees of efficacy (Dores & Lecaude, 
2005). However, MC2R can only be activated by ACTH, and therefore, a closer look at 
this polypeptide is warranted.  
A Highly Conserved Melanocortin Peptide: Adrenocorticotropin Hormone (ACTH) 
Human ACTH is composed of 39 amino acids and can be found in all vertebrates 
because of the important role this hormone plays in glucocorticol biosynthesis. However, 
it should be noted that within the ACTH peptide, only a certain number of amino acid 
residues are needed for functionality; the critical domains lie within the first 24 amino 
acid residues (Dores & Lecaude, 2005). In Figure 4, the POMC amino acid products are 
designated by different colors. Both human and Xenopus tropicalis (amphibian) ACTH 
sequences are strikingly similar with only a few differences lying within the 39 amino 
acid residues, which suggests that the conservation in the melanocortin peptide sequence 
is of importance for the fitness of the organism. As noted, all four melanocortin peptides 
shown in Figure 4.b, have the four amino acid motif, histidine-phenylalanine-arginine-
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tryptophan (HFRW). The HFRW domain within a melanocortin peptide is required for 
the activation of all of the melanocortin receptors. This relationship was established by 
studies done in the 70’s on the MSH receptor (i.e., MC1R) and the ACTH receptor (i.e., 
MC2R) as summarized in the review article by Robert Schwyzer (Schwyzer, 1977). 
In Schwyzer’s review (1977), he suggests that the location of the “activation 
motif” within ACTH was within the first 24 amino acids of the polypeptide because of in 
vivo experiments carried out with elongated or shortened sequences of human ACTH(1-
39). He demonstrated that high corticotropic activity was observed with human ACTH N-
terminal amino acid residues 1-19, 1-20, 1-23, and 1-24. Thus, he found that H
6
 F
7
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8
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9
  
motif located within amino acid residues 1-10 of ACTH was essential for activation of 
the ACTH receptor. Furthermore, he proposed that another site within ACTH(1-24) acted 
as a type of “address” domain to direct or to position the HFRW stimulatory domain in 
the proper position on the receptor so that activation of the ACTH receptor would occur. 
He proposed that this important address sequence is located at residues 15-18 at the 
Lysine-Lysine-Arginine-Arginine or KKRR motif (Schwyzer, 1977). At this stage it 
would desirable to focus on the nature of the ACTH (aka MC2R) receptor.  
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The Physiological Relationship between Glucocorticoid Production, ACTH, & MC2R 
 In terms of the MC2R receptor and glucocorticoid production, the hypothalamus-
pituitary-adrenal axis (HPA) should be mentioned to understand how this receptor is part 
of a neuroendocrine circuit that can respond to stress. As shown in Figure 5, 
Corticotropin-releasing factor (CRF) is a 41-amino acid polypeptide that is found in the 
hypothalamus, and was first isolated from a sheep; CRF plays an important role in 
regulating the stress response. When stress is introduced to an organism, CRF mRNA 
levels elevate in parts of the brain, such as the paraventricular nucleus (PVN), locus 
coeruleus, Barrington’s nucleus and bed nucleus of stria terminalis. As CRF levels 
increase within the hypothalamus, CRF receptor type 1 (CRF1 receptor) is expressed on 
the anterior pituitary. CRF is released from the hypothalamus into a capillary bed, the 
median eminence, where it binds to the CRF1 receptor (Kageyama & Suda, 2009). CRF1 
receptor stimulation activates the synthesis and secretion of ACTH from the corticotropic 
cells located within the anterior pituitary. In turn, ACTH secretion activates 
glucocorticoid production by binding to the MC2R receptor located on the adrenal cortex 
(Kageyama & Suda, 2009). As illustrated in Figure 5, the HPA axis is regulated by 
negative feedbacks loops, which turn off the production of ACTH or CRF in response to 
elevated levels of circulating cortisol.  
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Figure 5: Hypothalamus-Pituitary Axis Involving Cortisol Release 
 
http://www.montana.edu/wwwai/imsd/alcohol/Vanessa/vwhpa.htm 
 When ACTH is present, the MC2R is specifically expressed to activate a 
biosynthetic pathway to release cortisol from the target cell of the adrenal cortex. As seen 
in Figure 6, the biosynthesis of this hormone occurs within the zona fasiculata and zona 
reticularis of the adrenal cortex. The steroid, cholesterol, is broken down by enzymes 
into an intermediate, progesterone, and then more specific enzymatic reactions produce 
cortisol (Barrett, 2003). Cortisol’s functions span throughout they physiological system, 
and therefore, it is considered an important glucocorticoid hormone. Mainly, it functions 
to regulate stress and restore homeostasis within the body. Although its primary targets 
involve metabolism, it can be involved in ion transport and the physiology of the immune 
system as well. Additionally, when acute stress is introduced to the body, cortisol 
stimulates gluconeogenesis, the synthesis of glucose, in the liver (Cooper & Hausman, 
10 
2009). Prior to 1992, while there was no doubt that an “ACTH’ receptor was present on 
adrenal cortex cells, the biochemical structure of that receptor had not been determined. 
This discovery will be discussed next.  
Figure 6: Biosynthetic Pathway of Adrenal Steroid Hormones 
 
http://openi.nlm.nih.gov/detailedresult.php?img=2908652_wjem-11-161f1&req=4 
MC2R: A Unique Melanocortin Receptor 
In 1992, Mountjoy et. al, knew that ACTH and β-endorphin were co-expressed in 
the anterior pituitary in response to stimulation by CRF. Also, they acknowledged the 
relationship between ACTH and α-MSH in that both these neuropeptides bind to G 
protein-coupled receptors found in the brain, as well as, melanocytes, and the adrenal 
cortex. However, the sequence and site of expression of these specific G protein-coupled 
receptors was yet to be discovered. Therefore, Mountjoy’s group hypothesized that these 
specific receptors would share sequence similarity with other G protein-coupled 
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receptors. First, they determined by DNA sequencing, two PCR fragments that encoded 
G protein-coupled receptors one of which was   a substantial part of the MSH-R, or the 
MC1R receptor. By carrying out a Northern hybridization assay, this group discovered 
that more than one fragment held specific sites of expression in melanocytes and the 
adrenal cortex. Furthermore, they screened two sequences against the human genomic 
library, and isolated the gene sequences of the MC1R and MC2R receptor, which they 
referred to as the MSH-R and ACTH-R respectively. To further support their findings of 
these genomic sequences, they wanted to functionally test these genes with their 
corresponding peptide, and therefore, carried out functional assay experiments. In these 
experiments, specific cell lines were used to express the MSH-R and ACTH-R. The 
MSH-R and ACTH-R were then stimulated with different concentrations of their 
corresponding neuropeptides, and increased cAMP levels were detected in the cells. 
Therefore, these assays represent compelling evidence that they had discovered both 
MSH-R and ACTH-R genes. However, the location of these two receptors was still 
lacking in experimental data. First, they carried out a Northern Blot to test how much 
mRNA could be detected in different types of tissues. They found that an abundance of 
MSH-R mRNA could be found in human melanocyte samples. Also, this group found the 
presence of ACTH-R mRNA in monkey adrenal gland tissue. Overall, Mountjoy’s group 
provided strong evidence two separate genes code for MC1R and MC2R, as well as, 
proving that these genes are expressed in specific tissues within an organism (Mountjoy 
et al., 1992).  
12 
Although Mountjoy’s group was able to express and functionally test the human 
MC2R, they were limited to using a mammalian cell line, Cloudman S91 melanoma cells. 
This cell line endogenously expressed MC1R, thus making analysis of the unique 
properties of MC2R difficult to interpret in this particular cell line. However, Rached et 
al. (2005) successfully expressed the human MC2R in two different eukaryotic cell lines, 
M3 melanoma and HEK293, in 2004. In this study Rached et al. (2005) first stably 
expressed the human MC3R and MC4R genes in HEK293 cells. In these experiments 
each melanocortin receptor was tagged at the C-terminus with an enhanced green 
fluorescent protein (EGFP). Thus the receptors could be visualized using fluorescent 
microscopy. The EGFP-tagged human MC3R and MC4R fluoresced along the plasma 
membrane of the HEK 239 cells, and this was to be expected because of previous 
research in 2000 and 2003 (Rached et al. (2005). However, when EGFP- tagged human 
MC2R was expressed in HEK293 cells, the labeled receptor could be detected within the 
cytosol of these cells, not on the plasma membrane. These results suggested that the 
human MC2R required some chaperone to facilitate trafficking of the receptor to the 
plasma membrane (Rached et al., 2005). 
Clinical observations also indicated that some chaperone may be needed to 
facilitate the activation of MC2R. Familial glucocorticoid deficiency (FGD) is a genetic, 
autosomal recessive disease where individuals become insensitive to ACTH levels. In 
turn, this ACTH resistance causes alarmingly low glucocorticoid output from the adrenal 
cortex, accompanied by high levels of ACTH. The deficient levels of cortisol in the 
circulatory system interrupt the development of some organ systems in newborns and this 
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condition can be fatal. Mutations within the MC2R receptor are responsible for at least 
one fourth of FGD cases and this condition is designated as Type I FGD (Hinkle & 
Sebag, 2009). Several different mutations within the human MC2R have been shown to 
cause Type 1 FGD, and in turn, individuals become insensitive to ACTH (Chan et al., 
2008). Another 50% of FGD cases are caused by errors in the glucocorticoid biosynthetic 
pathway. However, in approximately 25% of FGD cases there is no evidence of mutation 
in MC2R, and there are no errors in the expression of the enzymes that make cortisol. 
Clearly in these patients a protein that interacts with MC2R is the problem. 
MRAP: An Essential Accessory Protein for MC2R Trafficking & Functionality 
 Melanocortin Receptor Accessory Protein (MRAP) was discovered by clinical 
researchers, Metherell et al, (2005) who studied a group of individuals diagnosed with 
FGD, but who had no mutations within their MC2R receptor. Therefore, they mapped a 
region of the human genome that was connected to FGD, and studied the expression of 
30 susceptible genes in the adrenal cortex, while comparing genes from the liver and 
brain (Metherell et al., 2005). By comparing and contrasting these specific genes, the 
group was able to identify a gene that encoded for protein with a single transmembrane 
spanning domain. Tissue analysis observed that the protein’s gene, C21orf61, was 
expressed in adrenal tissue, but not in the brain or liver (Webb & Clark, 2010). As it 
turned out, this small protein played a major role in the successful expression of a 
functional MC2R receptor in adrenal tissue. Interestingly, MRAP is the first GPCR 
accessory protein to be implicated in causing a disease, and 9 different mutations within 
MRAP have been found in FGD patients. Because the mutations causing FGD were 
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found in MRAP and not the MC2R receptor, this form of the disease was designated as 
Type II FGD. Additionally, MRAP was previously identified as fat cell-specific low 
molecular weight protein (Falp) because of the appearance of its transcript only when 
differentiation occurred within adipocytes (Hinkle & Sebag, 2009). 
 As mentioned above, MRAP is a small protein consisting of one transmembrane 
domain. MRAP mRNA can be found in many parts of the mammalian body, such as the 
adrenal cortex, lymph nodes, brain, testis, breast, thyroid, and adipose tissue.  The gene 
that encodes for this mammalian accessory protein consists of 6 exons. Alternate splicing 
of these exons can create two different MRAP products: Human MRAPα and MRAPβ 
(Hinkle & Sebag, 2009). The exons 3 and 5 encode for MRAPα, which is made up of 172 
amino acids. On the other hand, exons 4 and 6 give rise to the 102 amino acid isoform, 
MRAPβ. However, the crucial transmembrane domain of MRAP is encoded by exon 4, 
and therefore, the two isoforms of MRAP have identical N-termini, as well as, 
transmembrane domains (Webb and Clark, 2010). Specifically, the 37 amino acid N-
terminal sequence, the 23 amino acid transmembrane domain, and the first 9 residues of 
the C-terminal are identical in MRAPα and β (Hinkle & Sebag, 2009). However, MRAPα 
and β differ by many residues in their C-termini (Webb and Clark, 2010). Therefore, 
these findings suggest a level of conservation in the amino acid sequence of MRAP; 
particularly at the N-terminal and transmembrane domain. Although these isoforms of 
MRAP differ slightly in their C-termini, it is interesting to find that Roy et al. (2007) 
discovered cAMP production occurring within a heterologous cell line while 
coexpressing the MC2 receptor and the MRAP isoforms. 
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 In terms of MRAP’s structural properties, it is necessary to mention the 
importance of MRAP’s orientation in the endoplasmic reticulum (ER) and the plasma 
membrane because of its complex interaction with the MC2R. Through topology analysis 
programming, Viklund & Elofsson (2004) predicted that MRAP was a type II integral 
membrane protein with a C-terminal that faced the inside of the ER and Golgi apparatus. 
On the other hand, it was hypothesized that this same C-terminus of MRAP was exposed 
to the exterior of the cell when MRAP was expressed on the cell membrane. 
Interestingly, Sebag and Hinkle (2008) found that both mouse MRAP’s N- and C- termini 
were oriented extracellularly while being expressed on the surface of CHO cells. 
Therefore, a dual topology of MRAP was discovered, and found to be completely 
independent of the MC2R receptor (Hinkle & Sebag, 2009). Therefore, to confirm 
MRAP’s dual topology, Hinkle and Sebag performed two critical experiments where 
endogenous MRAP was expressed in adrenocortical cells. By tagging MRAP’s N- and C-
termini, they found that both ends of MRAP were found on the endoplasmic reticulum as 
well as the plasma membrane. In another experiment, they used an adrenal cell line, OS3, 
where the MC2 receptor is not endogenously expressed, and found that the tagged MRAP 
produced the same results on the surface of the cell. Therefore, this suggests that 
MRAP’s dual topology occurs independently of the MC2R. Furthermore, studies have 
generated convincing data that MRAP’s dual topology implies formation of a 
homodimer. Corray et al. (2008) found that MRAP’s size was comparable to that of 
dimers by using electrophoresis and mass spectrometry to confirm molecular weight. 
Furthermore, antibodies were used to test against two differently tagged MRAPs which 
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were coexpressed in CHO cells. Immunoprecipitation found that both MRAPs 
coprecipitated, indicating the presence of dimer formation (Corray et al., 2008). In 
addition, Hinkle and Sebag (2008) performed a set of experiments where they tagged 
both N- and C-termini, and found that the C-terminus of MRAP existed in both 
glycosylated and unglycoslyated forms suggesting that MRAP structure forms an 
antiparallel homodimer. Therefore, this evidence of MRAP’s dimeric properties suggests 
that this accessory protein would form a complex with the MC2 receptor, and in turn, 
facilitate proper function of the receptor. 
 The direct interaction of MRAP with the MC2 receptor is required for proper 
trafficking, and activation of MC2R. Webb et al. (2009) suggests that the functional 
domain of MRAP lies within the N-terminus and the transmembrane domain because of 
high level of conservation within these two regions of the accessory protein. By using 
truncation constructs of MRAP at both regions they were able to provide strong evidence 
that the transmembrane domain was responsible for the direct interaction between human 
MRAP and the MC2 receptor. Furthermore, they discovered that the N-terminus of 
MRAP is required for the MC2 receptor’s surface expression, as well as, the receptor’s 
affinity to be activated by ACTH (Webb et al., 2009). In addition, multiple research 
studies showed that cAMP production is affected by the presence or absence of MRAP. If 
MRAP was not expressed with the MC2 receptor, then cAMP production was 
insignificant. On the other hand, cAMP production increased significantly when MRAP 
and the MC2 receptor were co-expressed in mammalian cells lines (Metherell et al., 
2005; Roy et al., 2007; Hinkle & Sebag, 2008). Figure 7 illustrates how MRAP 
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interaction and MC2R activation can be broken down in three steps. First, the MC2 
receptor and MRAP form a complex at the endoplasmic reticulum. Second, MRAP 
facilitates the trafficking of the MC2R to the plasma membrane. Third, MRAP not only 
enables the receptor to traffic to the membrane, but also increases the binding affinity of 
the receptor for ACTH. Finally, a signal is transducted into the intracellular compartment 
of the cell to produce cAMP.   
Figure 7: Interaction of MC2 Receptor and MRAP
 
http://www.sciencedirect.com/science/article/pii/S1521690X08001048 
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Evolution of the Melanocortin-2 Receptor  
 Comparative studies have proposed that the evolution of the melanocortin 
receptor family is complex. What seems to be even more perplexing is the evolution of 
one melanocortin receptor in particular: the MC2R. This receptor’s evolution creates an 
interesting story because of its intimate relationship with POMC products, ACTH, and 
MRAP. While MC2R depends on these two components for proper functionality and 
trafficking, their evolutionary trends seem to parallel that of the MC2 receptor. Therefore, 
a comparative analysis on the origin of the melanocortin receptors is necessary to 
understand the occurrence of the MC2R, as well as, observe any similar trends in POMC 
and MRAP evolution. It should be mentioned that genomic databases have revealed the 
absence of orthologous genes in protostomes, as well as, many deuterostomes. On the 
other hand, genomic comparisons have revealed MCR-related genes in hagfish, lamprey, 
cartilaginous fish, teleost, and tetrapod genomes. Therefore, these genomic data suggests 
that the MCR family is only found in chordates (Dores, 2013).   
In 1994, comparative studies suggested that the melanocortin receptor family 
evolved from an ancestral gene found in protochordates (Holland et al., 1994). This 
single gene was subjected to two separate genomic duplication events, in which the first 
created two paralogous genes, and the second yielded four paralogous genes (Holland et 
al, 1994). The first duplication event seems likely because of two MCR genes that have 
been cloned from the lamprey genome (Haitina et al., 2007; Baron et al., 2008). Also, 
evidence of the second genomic duplication comes from bony fish in which MC1R, 
MC2R, MC4R and MC5R genes have been observed in the fugu genome while an 
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ortholog of the MC3R gene is found in zebrafish (Klovins et al., 2004; Baron et al., 2008; 
Ringholm et al., 2002). Furthermore, it was proposed that the MC2R and the MC5R 
receptors resulted from a local gene duplication dating back to the early gnathostomes 
because these receptors’ genes are found on the same chromosome (Fredriksoon et al, 
2003; Klovins et al., 2004; Baron et al, 2008). Therefore, a phylogenic tree of the 
melanocortin receptors was established due to sequence alignments of the receptors from 
different chordates. Figure 8 illustrates an early rendition of melanocortin receptor 
evolution as a result of the genome duplication events that lead to five distinct 
melanocortin receptors (Baron et al, 2008). Although this seems to be a logical 
hypothesis, the evolution of the melanocortin receptor family proved to be more complex 
because of recent findings involving the MC2R, MC4R, and MC5R. 
Although the MC2R and MC5R genes are located in close proximity to one 
another on the same chromosome, their evolutionary origins have been called in question. 
Alignment of the MC2R and MC5R amino acid sequences reveals that these two 
receptors differ greatly from one another. Therefore, this would suggest that a local gene 
duplication of the MC2R and MC5R genes proves to be a weak hypothesis without 
further investigation. Therefore, another evolutionary scenario is introduced to include 
the MC4R because of its similarity in amino acid sequence with that of the MC5R. 
Therefore, these data implies that the MC5R gene resulted from a local duplication of the 
MC4R gene (Vastermark and Schioth, 2011).  
In turn, a new evolutionary phylogeny hypothesis of the melanocortin receptors 
could be established to include the MC2R/MC5R local duplication and the MC4R/MC5R 
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relationship. Figure 9 illustrates this new explanation of melanocortin evolution where 
the MC4R gene is considered the ancestral gene (Dores, 2013). If the MC4R gene is the 
“original” melanocortin gene, then genome and local gene duplications would result in 
the paralog genes containing a conserved motif of amino acids from the ancestral MC4R 
gene. Synteny studies have shown that it is possible for the MC2R/MC5R gene to 
undergo a local duplication dating back to ancestral gnathostomes (Schioth et al., 2003; 
Dores, 2013). Therefore, it has been suggested that this duplication event selected for the 
MC5R gene, and therefore, retained sequence similarities with its ancestral gene. 
Consequently, its “partner” gene, the MC2R, underwent a different fate. The MC2R gene 
was subjected to mutations, and in turn, its functionality would be forever different from 
the rest of the melanocortin family (Dores, 2013). 
Main Objectives 
 These observations have focused on the structure, functionality, and evolution of 
the mammalian MC2 receptor. Also, the mammalian MC2R’s activation by ACTH has 
been carefully analyzed in past studies. More specifically, past research has asked these 
questions: Does the mammalian MC2 receptor have specific binding sites for ACTH? Do 
these binding sites rely on crucial ACTH amino acid motifs to ensure proper function of 
the MC2 receptor? (Liang, 2013) has tried to answer these questions about the human 
MC2R. The data have suggested that key ACTH motifs exist within the first 24 amino 
acids, and therefore, corresponding binding sites on the mammalian MC2 receptor can be 
established within the receptor’s sequence. Therefore, could these same questions be 
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asked of a different species of chordate to gain a better understanding of the MC2 
receptor’s evolution?   
 Based on these findings of the mammalian MC2R, this study has two different 
objectives, which involve the amphibian, Xenopus tropicalis, MC2 receptor. The first 
objective was to answer this question: what regions of ACTH are responsible for the 
activation of X. tropicalis MC2 receptor? Our hypothesis suggests that there are three 
important regions of ACTH that are required for the successful activation of the MC2 
receptor. As mentioned above, ACTH is a polypeptide chain consisting of 39 amino 
acids. However, only the first 24 amino acids are required for activation of the receptor 
because of the high level of conservation within this area of the peptide (Schwyzer, 
1977). Although the wild type X. tropicalis MC2R is utilized in the following 
experiments, we used the mammalian melanocortin, human ACTH(1-24). We were able 
to use the mammalian ACTH(1-24) because of its high level of sequence similarity with 
the amphibian ACTH peptide (Figure 3A). The first zone of ACTH(1-24), Zone A, 
consists of amino acids 6-9, which are HFRW (Histidine-Phenylalanine-Arginine-
Tryptophan). This crucial motif is found in several of the melanocortin peptides (Cone, 
2006). The second region we analyzed was Zone B, which was made up amino acids 10-
14, GKPVG (Glycine-Lysine-Proline-Valine-Glycine). The third region of ACTH(1-24), 
Zone C, is made up of amino acids KKRRP (Lysine-Lysine-Arginine-Arginine-Proline). 
To test the importance of these three regions in ACTH(1-24), we replaced individual 
amino acids within each zone, and stimulated the wild type X. tropicalis MC2 receptor 
with these ACTH(1-24) analogs to produce a dose response curve. By analyzing these 
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zones of ACTH(1-24), we believe that the activation of the X. tropicalis MC2R could be 
quite similar to that of human MC2R. Therefore, the hypothesized mechanism for the X. 
tropicalis MC2R can be broken down into three major steps. First, the C-terminus region 
of ACTH(1-24), Zone C, would make contact with its corresponding binding site on the 
X. tropicalis MC2R. In turn, this specific binding induces a conformational change in the 
receptor, and the second binding site is exposed. Third, Zone A, HFRW, is able to bind to 
the receptor’s second site, and activate the G-protein of the receptor (Baron et al. 2008; 
Liang, 2013).  
 The second objective of this study focused on this question: what regions of the 
amphibian MC2 receptor bind to ACTH? Since we believe that the amphibian MC2R 
activation is similar to that of the mammalian MC2R, it would be logical to suggest that 
these receptors would have a similar binding complex model. The theoretical model 
illustrates the amphibian receptor having two binding pockets like that of the human 
receptor. The first binding pocket is utilized as a docking pocket for the C-terminal amino 
acids of ACTH(1-24), Zone C. The second binding pocket is responsible for the binding 
of the HFRW motif, Zone A, so that activation of the receptor may occur. It has been 
hypothesized that the second binding pocket consists of the receptors transmembrane 
regions 4 (TM4) and 5 (TM5), as well as, extracellular loop 2 (EC2). To test this second 
binding pocket hypothesis, we replaced single amino acids within TM4, TM5, and EC2 
regions with alanine, and then stimulated these mutants with ACTH(1-24) to produce a 
dose response. Additionally, it is important to note that Zone B is utilized as an adapter 
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region of ACTH(1-24), and without this sequence of residues Zone C and Zone A would 
not be properly situated within the binding pockets of the receptor (Liang, 2013). 
Figure 8: “Early” Melanocortin Receptor Phylogenic Tree  
 
Figure 9: Revised Melanocortin Receptor Phylogenic Tree 
 
(Both Figures are adapted from Dores, 2013)
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Materials and Methods 
Tissue Culture 
 Experiments were done utilizing Chinese Hamster Ovary (CHO) cells (ATCC, 
VA). The cells were grown in Kaighn’s Modification of Ham’s F12K media supplied by 
ATCC. Media was supplemented with 10% fetal bovine serum, 10 unit/ml penicillin, 100 
µg/ml streptomycin, and 100 µg/ml normacin (CHO media) The cells were grown in a 25 
cm
3
 tissue culture flask with vent cap by CELLTREAT
TM
, and maintained in an 
incubator with 95% air, 5% CO2 at 37ºC, and exposed to humidity. When the CHO cells 
reached 70% confluence, cells were split into new culture flasks using 0.05% trypsin/0.53 
mM EDTA produced by CORNING  cellgro
TM
.  
DNA Constructs 
 The amphibian, Xenopus tropicalis, MC2R (xtMC2R; Accession No.: 
XP_003215733) cDNA construct was synthesized by GenScript (Piscataway, NJ). This 
receptor was tagged at the N-terminus with a V-5 epitope, and inserted into a 
pcDNA33.1+ vector. In addition, the mammalian, Mus musculus (mouse), MRAP1 
(mMRAP1; Accession No.: NM_029844) was synthesized by GenScript, tagged at its N-
terminus with a FLAG epitope, and inserted into a pcDNA3.1+ vector as well. The 
cAMP reporter, CRE-Luc (Chepurny and Holz, 2007), was provided by Dr. Patricia 
Hinkle (University of Rochester, NY). A set of alanine-substituted mutants of the wild 
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type  Xenopus tropicalis MC2R was also made by GenScript. Each of these cDNA 
constructs had a V5 epitope tag and was inserted into the pcDNA3.1+ vector. 
Individually, mutations were introduced to the Xenopus tropicalis MC2R by site-directed 
mutagenesis. Single alanine substitutions were made at TM4, EC2, and TM5 are 
illustrated in Figure 10. 
ACTH Analog Peptides 
 The melanocortin peptide used in the experiments was human ACTH(1-24), and 
this synthetic hormone was purchased from Sigma-Aldrich Inc. located in Saint Louis, 
MO. Additionally, the human ACTH(1-24) analogs include alanine substitutions, as well 
as, truncated forms of ACTH(1-24) which were made by New England Peptide Inc. in 
Boston, MA. The amino acid sequence of hACTH(1-24), the analogs, and truncated 
peptides used in this study can be found in Table 1.  
Immunocytochemistry 
 For immunocytochemical experiments, the CHO cells were plated in 8-well 
chamber slides at 2.5x10
4
 cells per well. After 24 hours, the cells were transfected with 1 
µg of the cDNA constructs by using Lipfectamine 2000 (Invitrogen, Carlsbad, CA) in an 
OptiMEM medium (Madiateach Inc., Herndon, VA). Experiments were done on cells 
transfected with xtMC2R V5 tagged cDNA alone or xtMC2R V5 tagged cDNA and 
mMRAP1 Flag tagged cDNA. Transfected cells were incubated for 24 hours at 37ºC. 
Next, the transfected CHO cells were fixed with a 4% PFA solution for 15 minutes, and 
then all wells were washed with a 1xPBS solution. At this stage, half of the wells (4 
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wells) were permeablized with a 0.3% Triton X-100 for 10 minutes, while the other 4 
wells were left in the 1xPBS solution (unpermeablized). The primary antibodies, mouse 
anti-V5 and the rabbit anti-FLAG, were used to detect the receptor and MRAP 
respectively. It should be noted that both primary antibodies were diluted to 1:500, and 
applied to the cells for 1 hour at 37ºC. After three washes with the 1xPBS solution, cells 
were incubated with the respective secondary antibodies, donkey anti-mouse conjugated 
with Alexa388 and donkey anti-rabbit conjugated with Alexa555, for the receptor and 
MRAP respectively. These secondary antibodies were applied for 45 minutes at a 1:800 
dilution. After another three washes with 1xPBS, chambers were removed from slides. 
Coverslips were applied to the slides with Vecta-Shield from Vector Laboratories Inc., 
Burlingame, CA. Additionally, the nuclei were stained with DAPI (blue), and coverslips 
were sealed with clear nail polish. The slides were imaged using a fluorescent Zeiss 
Axioplan 2 microscope with a Hamamatsu digital camera. Finally, all slides were 
observed using a 100x oil immersion objective. The immunocytochemical images were 
analyzed using Slidebook software (www.slidebook.com). The negative control for the 
immunocytochemical staining slides were non-transfected CHO cells that did not include 
the cDNAs of interest to make sure that the CHO cells did not express receptor or 
accessory protein endogenously.  
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cAMP Reporter Assay (Luciferase Assay) 
 In the cAMP Reporter Assay, 2.5x10
6
 cells/reaction were used (24 wells of a 
white 96 wells plate = one reaction). It should be noted that 4 reactions could be 
performed on a white 96 well plate. Cells were co-transfected with 2µg of the following 
cDNA constructs: xtMC2R, mMRAP1, and CRE-Luciferase (Chepurny & Holz, 2007). 
Transfections were done utilizing the Amaxa Cell Line Nucleofector II system (Lonza 
Group, LTD, MD), 100 µl Solution T/reaction, and program U-23. After a 10 minute 
period of recovery in 500 µl of CHO media, the transfected cells were diluted in 7.5 mL 
of CHO media. It should be noted that the 600µL of reaction mixture should be mixed 
well in the dilution media, so that the mixture is homogenous to plate 1x10
5
 cells per well 
(300µL per well). After about 24 hours of the transfection, cells were fed with 300 µL of 
fresh CHO media.  
On the third day of the Luciferase Assay, the transfected cells were stimulated 
with hACTH(1-24) or hACTH(1-24) analogs. Using serum-free CHO Media (does not 
contain FBS), serial dilutions were carried out with the wild type peptide or the analogs, 
at concentrations ranging from 10
-6
 to 10
12 
M. In addition, each dose was tested in 
triplicate. Then, the stimulated plate was incubated at 37ºC incubator for 4 hours. After 
the 4 hour stimulation period, the plate was allowed to cool to room temperature, and the 
stimulation solution was removed.. Next, a 1:1 ratio of serum free CHO media and 
Luciferase substrate reagent Bright GLO (Promega, WI) was gently mixed in a 15 mL 
conical tube. The Luciferase substrate solution was applied to each well (100 µL/well), 
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and allowed to incubate at room temperature for 5 minutes. Finally, luminescence of each 
well was measured using the Bio-Tek Syngergy HT plate reader (Winooski, VT).  
Additionally, basal levels of cAMP production needed to be determined to 
produce an accurate activation curve. Therefore, a negative control was included in each 
assay where the transfected CHO cells were not stimulated with wild type ACTH(1-24) 
or the analog peptides used in the experiment. The negative control was subtracted from 
each data point, and the corrected data points for each dose response curve were fit to the 
Michaelis-Menton equation to produce an EC50 value for each activation curve. These 
activation curves were analyzed by using Kaleidograph software (www.syngery.com). 
Statistical Analysis 
 Data points were calculated as a mean with standard error values that were 
obtained from experiments performed in a triplicate. To determine statistical significance 
between experimental treatments and their corresponding controls, an unpaired two-tailed 
Student’s t-test for equal variance was calculated; significance was set at P ≤ 0.05.  
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Figure 10: Two Dimensional Structure of Xenopus tropicalis MC2R 
 
  
 = normal amino acid sequence of xt.MC2R 
 
 
 
= TM4 alanine substitution sites 
= EC2 alanine substitution sites 
= TM5 alanine substitution sites 
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Table 1: Human ACTH(1-24) Wild Type Peptide and Analogs. The alanine 
substitutions that have replaced amino acids in the peptide are underlined. 
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Results 
Immunocytochemistry of the Xenopus tropicalis MC2 Receptor and Mouse MRAP1 
      Several studies had shown that functional expression of mammalian MC2Rs in 
heterologous mammalian cells, such as CHO cells, required co-expression with the 
accessory protein, MRAP1 (Webb and Clark, 2010, Hinkle and Sebag, 2010). Would this 
same restriction apply to other tetrapod MC2Rs? To initially address this question, an 
immunofluorescence approach was used to determine whether a V5-epitope tagged 
xtMC2R cDNA construct also required MRAP1 for trafficking to the plasma membrane. 
As a control, non-transfected CHO cells were reacted with the V5 primary antiserum and 
the V5 secondary antiserum (Figure 11A), and the cells were left non-permeabilized. 
Note that no reaction was observed. This outcome indicated that the V5 antiserum did not 
react with any polypeptides on the surface of non-transfected cells.  In the next 
experiment (Figure 11B), CHO cells were transfected with the V5-tagged xtMC2R 
cDNA construct alone, and the immunofluorescence reaction was once again done on 
non-permeablized cells. No reaction was observed. This outcome could indicate a 
problem with the expression of the xtMC2R cDNA construct, hence the experiment was 
repeated, but the transfected cells were permeabilized (Figure 11C). Note the intense 
reaction in the cytoplasm of the transfected cells. Collectively, Figures 11B and 11C 
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indicate that the CHO cells could express the V5-tagged xtMC2R cDNA construct, but 
the receptor was not moving to the plasma membrane of the transfected cells.  
      In the next series of experiments (Figure 11D, E, F), CHO cells were co-transfected 
with a V5-tagged xtMC2R cDNA construct and a Flag-tagged mouse MRAP1 
(mMRAP1) cDNA construct. In these experiments the immunofluorescence reaction was 
performed on non-permeabilized cells. Figure 11D indicates that the V5-tagged xtMC2R 
can be clearly detected on the plasma membrane.  Figure 11E indicates that the Flag-
tagged mMRAP1 could also be detected on the plasma membrane. Figure 11F shows the 
immunofluorescence images merged, which is an indication that xtMC2R and mMRAP1 
are in close proximity on the plasma membrane. Collectively, these experiments provided 
the first evidence that an amphibian MC2R requires the presence of an MRAP1 to 
facilitate trafficking to the plasma membrane. As a result, in all subsequent experiments 
the xtMC2R cDNA construct was co-expressed with mMRAP1. Mouse MRAP1 was 
used for functional assay experiments due to the fact that a X. tropicalis MRAP1 ortholog 
had not been detected in the X. tropicalis genome project (web site for xt genome 
project).  The operating assumption was that tetrapod MC2Rs should be able to interact 
with tetrapod MRAP1s. The following experiments supported this assumption.  
  The immunocytochemistry images (Figure 11) showed that the xtMC2R required 
co-expression with an MRAP to facilitate trafficking to the plasma membrane. The next 
question to address was whether xtMC2R could be functionally expressed in CHO cells; 
that is, was it possible to show cAMP production when xtMC2R was co-expressed with 
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mMRAP1?  The CHO cell system was also used to determine whether MRAP2, a paralog 
of MRAP1 had any effect on the activation of xtMC2R. These experiments utilized a 
cAMP reporter gene (CRE/Luciferase construct; see Methods) to measure the amount of 
cAMP produced following stimulation with human ACTH(1-24).  The rationale for using 
hACTH(1-24) was presented in the Introduction. 
Figure 11: Xenopus Tropicalis MC2R and Mouse MRAP1 Immunocytochemistry 
Images 
 
Immunocytochemical analysis of the Xenopus tropicalis MC2 receptor. For these 
experiments the xtMC2R receptor was tagged with a V-5 epitope and the mMRAP1 was 
tagged with a FLAG epitope. In all of the experiments nuclei were stained with DAPI. 
Permeabilized cells were pretreated with 0.3% Triton X-100 prior to application of the 
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V5 primary antiserum.  A) Non-permeabilized, non-transfected CHO cells were reacted 
with the V5 antiserum.  The arrow points to a DAPI stained nucleus. B) Non-
permeabilized CHO were transfected with xtMC2R cDNA construct only. The arrow 
points to a DAPI stained nucleus. C) Permeablized CHO cells were transfected with the 
xtMC2R cDNA construct only. The arrow points to fluorescence detected in the 
ER/Golgi complex. D) Non-permeablized CHO cells were co-transfected with the 
xtMC2R cDNA construct and mMRAP1 cDNA construct. This section was only reacted 
with the V5 antiserum. The arrow points to FITC fluorescence on the surface of the 
transfected cells. E) The same sections in “D” were reacted with Flag antiserum. The 
arrow points to CY3 fluorescence on the surface of the transfected cells. F) Images from 
“D” and “E” were merged and the co-localization of xtMC2R and mMRAP1 can be 
visualized as a neon-orange color on the cell membrane (arrow).  
Functional Expression of xtMC2R: Interactions with Mouse MRAP1 & 2 
        Figure 12 represents a collection of xtMC2R activation curves following stimulation 
with hACTH(1-24). When xtMC2R was expressed along (red circles) there was no 
evidence of a dose dependent increase in cAMP following stimulation with hACTH(1-
24). However, when xtMC2R and mMRAP1 were co-expressed, stimulation with 
hACTH(1-24) resulted in a dose dependent increase in cAMP production (blue squares). 
The EC50 for this dose response curve was 1.7 x 10
-9
 M; a value very similar to the EC50 
value reported by Liang et al. (2011).  
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Although an ortholog of MRAP1 has not been found in the X. tropicalis genome, 
an ortholog of MRAP2 has been found in this genome. Prior studies have shown that co-
expression of mammalian MC2Rs with mammalian MRAP2 resulted in a weak response 
when stimulated with ACTH(1-24) (Webb and Clark, 2010, Hinkle and Sebag, 2010). It 
seemed worthwhile to repeat this experiment using xtMC2R. As shown in Figure 12 
(green diamonds), co-expression of xtMC2R with mouse MRAP2 resulted in a weak 
stimulation of the transfected cells only at a concentration of 10
-6
M. These results are 
consistent with experiments done using mammalian MC2Rs (Hinkle and Sebag, 2010) 
and experiments done by Liang et al. (20110 using X. tropicalis MRAP2. Collectively 
these experiments indicate that tetrapod MRAP2s do not facilitate the activation of 
tetrapod MC2Rs.   
Figure 12: xtMC2R Co-Transfected with Mouse MRAP1 & 2 
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This figure represents a collection of xtMC2R activation curves following stimulation 
with hACTH(1-24); concentrations ranged from 10
-6
-10
-12
 M. CRE/Luciferase activity 
was measured as reported in Methods. The red circles in the response of xtMC2R 
expressed alone. Co-expression of xtMC2R and mMRAP1 (blue squares) resulted in a 
dose dependent increase in activation curve (EC50 of 1.7 x 10
-9
 M). However, co-
expression of xtMC2R  and mMRAP2 (green diamonds) only showed a minimal 
response at a ligand concentration of (10
-6
M). N = 3 for all experiments.   
xtMC2R Stimulation with Human ACTH(1-24) or NDP-MSH 
       Previous studies had shown that mammalian MC2Rs could be activated by 
mammalian ACTH(1-24) , but not by mammalian α-MSH (Schwyzer, 1977). This 
outcome is puzzling given that both ACTH(1-24) and α-MSH have the HFRW motif (see 
Introduction). These experiments were conducted to determine whether xtMC2R was 
also exclusively selective for ACTH, but not α-MSH. In Figure 13, xtMC2R was 
stimulated with NDP-MSH, an analog of α-MSH that is more potent than the native 
hormone. In this experiment, the positive control was stimulation with hACTH(1-24) (red 
circles; EC50 of 7.23 x 10
-9
 M). On the other hand, stimulation with NDP-MSH (α-MSH) 
resulted in no activation (blue squares). Based on these observations, it would appear that 
all tetrapod MC2Rs are exclusively selective for ACTH, but not α-MSH.  
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Figure 13: Wild Type Xenopus tropicalis MC2R Stimulated with hACTH(1-24) or α-
MSH 
 
Stimulation of xtMC2R with hACTH(1-24) (red circles) or NDP-MSH (blue square) at 
concentrations ranging from 10
-6
-10
-12
 M. Following hACTH(1-24) stimulation the EC50 
value was 7.2 x 10
-9
 M. N = 3.   
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XtMC2R: Human ACTH(1-24) Analog Studies 
       Prior to the characterization of the melanocortin-2 receptor as the “ACTH” receptor 
on mammalian adrenal cortex cells (Mountjoy et al., 1992), a considerable number of 
studies had been done on the structure/function relationship between mammalian ACTH 
and the “ACTH” adrenal cortex receptor (i.e., melanocortin-2 receptor). As noted 
previously, studies done in the 1970’s had established that the first twenty-four residues 
of mammalian ACTH(1-39) had full biological activity (Schwyzer, 1977). In addition, 
two domains in ACTH(1-24) were required for activation of the ACTH receptor (MC2R); 
the H
6
F
7
R
8
W
9
 motif (Eberle and Schwyzer, 1975; Schwyzer, 1977) and the 
K
15
K
16
R
17
R
18
P
19
 motif (Schwyzer, 1977; Costa et al., 2004; Liang et al., 2011). Finally, 
several studies had demonstrated that α-MSH [NAc-ACTH(1-13)NH2] cannot activate 
the “ACTH” receptor on mammalian adrenal cortex cells (Schwyzer, 1977; Buckley and 
Ramachandran, 1981; Mountjoy et al., 1992).  
          More recently, the HFRW and KKRRP motifs in hACTH(1-24) were examined in 
greater detail (Liang et al., 2013). In this study, hACTH(1-24) was divided into three 
functional zones: A – H6F7R8W9; B – G10K11P12V13G14; C -  K15K16R17R18P19 and single 
alanine or multiple alanine analogs of hACTH(1-24) were synthesized (Table 1 in 
Methods). The ability of these analogs to stimulate xtMC2R was tested by co-transfecting 
CHO cells with xtMC2R and mMRAP1. Activation was measured using the 
CRE/Luciferase cAMP reporter Assay. The positive control for these analog activation 
studies was stimulation of xtMC2R by human ACTH(1-24).   
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A) ACTH(1-24) Zone A Analogs: cAMP Assays 
 First, Zone A analogs (Table 1) were used to address the question of the relative 
importance of each amino acid in the HFRW motif with respect to the activation of the 
receptor. The results of these experiments are presented in Figure 14. The dose response 
curve for the positive control of this experiment is represented by red circles. As 
expected, the A4 (AAAA) analog was unable to activate the receptor (black triangle). 
However, what was not expected was that incubation with either the AFRW, HARW, 
HRAW, or the HFRA analogs also resulted in no stimulation at ligand concentrations of 
10
-7
M and lower. The AFRW and the HRAW analogs did produce a slight stimulation at 
the 10
-6
M concentration.  These results are summarized in Table 2. Given the dose 
response curves presented in Figure 14, it was not possible to calculate EC50 values for 
any of the Zone A. analogs.  It would appear that all of the positions in the HFRW motif 
are equally crucial for activation of xtMC2R. It should be noted that the Zone A 
stimulation results for xtMC2R are in sharp contrast to an earlier study on the human 
MC2 receptor (Liang et al. 2013). The differences in the responses of the two receptors to 
the Zone A analogs will be evaluated in the Discussion.  
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Figure 14: Wild Type Xenopus tropicalis MC2R & Human ACTH(1-24) Zone A 
Analogs 
 
This figure represents a collection of activation curves that resulted when xtMC2R was 
incubated with various Zone A analogs of human ACTH(1-24). Dilutions of analogs 
ranged from 10
-6
-10
-12
 M. Activation curves for the wild type hACTH(1-24) (red circles), 
the AFRW analog (orange right triangles), the HARW analog (blue squares), the HFAW 
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analog (green diamonds), the HFRA analog (pink squares), and the A4 analog (black 
triangles) are presented. N = 3.  
B) ACTH(1-24) Zone C Analogs: cAMP Assays 
 Past studies on the human MC2 receptor have indicated that the binding of 
KKRRP motif of hACTH(1-24) is a critical first step in the activation of hMC2R (Liang 
et al., 2013). In order to determine whether this same motif in hACTH(1-24) is also 
essential for the activation of  xtMC2R, three Zone C analogs were analyzed (Figure 15). 
The positive control for these experiments was xtMC2R stimulated with hACTH(1-24). 
The Zone C analogs were: A5 (A
15
 A
16
 A
17
 A
18
 A
19
), KKAAA, and AARRP, and 
the EC50 values for these analogs are presented in Table 2. As shown in Figure 15, there 
was no stimulation following incubation of xtMC2R with the A5 analog at any of the 
concentrations tested (black triangles). In addition, incubation of xtMC2R with either the 
KKAAA analog or the AARRP analog did not result in any stimulation at analog 
concentrations of 10
-7
M or less. However, there was minor stimulation at the 10
-6
M 
concentration. As a result of the weak activation at the highest concentration of ligand it 
was possible to generate estimates of the EC50 values for the KKAAA and AARRP 
experiments. The estimated EC50 value for the KKAAA analog was 3.7 x 10
-6
 M; a 512 
fold shift in activation as compared to the positive control (Table 2). The estimated EC50 
value for AARRP analog was 5.0 x 10
-6
 M; a 692 fold shift in stimulation as compared to 
the positive control (Table 2). It would appear that KKRRP motif of ACTH(1-24) is 
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required for the activation of xtMC2R. The role this motif may play in the activation 
process will be considered in the Discussion.  
Figure 15: Wild Type X. tropicalis MC2R & Human ACTH(1-24) Zone C Analogs 
 
This figure represents a collection of activation curves that resulted when xtMC2R was 
incubated with various Zone C analogs of human ACTH(1-24). Dilutions of analogs 
ranged from 10
-6
-10
-12
 M concentrations. For the positive control xtMC2R was stimulated 
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with  hACTH(1-24) (red dots). The results of stimulating with the A5 analog (blue 
squares), KKAAA analog (green diamonds),  and the AARRPP analog (black triangles) 
are presented. N = 3. 
C) ACTH(1-24) Zone B Analogs: cAMP Assays 
While it was expected that both Zones A and C in hACTH(1-24) have roles in the 
activation of xtMC2R, it seemed appropriate to determine whether the Zone B motif 
(GKPVG) also has a role in the activation process. The GKPVG motif in ACTH(1-24) is 
highly conserved among the gnathostome vertebrates, and only a single amino acid 
difference (M
13
 for V
13
) has been observed in gnathostomes ranging from the 
cartilaginous fishes to mammals (Dores and Baron, 2011). A recent study on human 
MC2R indicated that the Zone B motif may play a role  in the positioning of the HFRW 
and KKRRP motifs of ACTH(1-24) into their proposed binding sites on the receptor  
(Liang et al, 2013). That study indicated that while single or double alanine substitutions 
in the Zone B motif had no effect on activation, replacement of all residues in this motif 
with alanines had a significant effect on activation (Liang et al, 2013). The following 
experiments were done to determine if xtMC2R responded in a similar manner to the 
Zone B alanine analogs.   
Figure 16 presents a collection of activation curves that evaluated the effects of 
Zone B analogs on the stimulation of xtMC2R. For the positive control for this 
experiment (red circles), xtMC2R was stimulated with hACTH(1-24).  Incubation with 
the   A10-14 (AAAAA; blue squares), did not result in any stimulation of the receptor at 
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ligand concentrations tested at 10
-7
M or less. There was slight stimulation at a ligand 
concentration of 10
-6
M. Similar results were observed when this analog was used to 
stimulate human MC2R (Liang et al., 2013). Although this analog shows some cAMP 
production, the response proved to be too weak, and therefore, no EC50 could be 
calculated for A10-14 (Table 2). For the A10/14 analog the two glycines at  
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Figure 16: Wild Type Xenopus tropicalis MC2R & Human ACTH(1-24) Zone B 
Analogs
 
This figure represents a collection of activation curves based on cAMP production due to 
the stimulation of xt.MC2R with Zone B analogs of human ACTH(1-24). Dilutions of 
analogs ranged from 10
-6
-10
-12
 M. The positive control, xtMC2R, was stimulated with 
hACTH(1-24) (red dots). The results of stimulating with A10-14 analog (blue squares), 
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the KP (green diamonds), the P12 (black right-triangles), and the A10/14 analog (pink 
squares) are shown, N = 3.  
 
positions 10 and 14 were each replaced with an alanine residue (Table 1). While a dose 
response curve was generated by this analog (pink-white squares), there was a significant 
decrease in cAMP production relative to the positive control (p = 0.01), and a 25 fold 
change in the EC50 value (1.8 x 10
-7
 M; p < 0.02) relative to the positive control (Table 
2).  
For the KP analog, alanine substitutions were done at K
11
 and P
12
 (green 
diamonds). The KP analog generated a dose response curve with an EC50 value of 3.1 x 
10
-7
 M (Table 2). This is a 43 fold shift in sensitivity for the ligand (Table 2). The t-test 
for this EC50 value relative to the control was p < 0.00003 (Table 2). Therefore, these 
results indicate that K
11
 and P
12
 play a role in the activation of the receptor.   
The P12 analog (alanine substitution at position 12) generated a dose response 
curve (black right-triangles) with an EC50 value of 5.6 x 10
-8
 M (Table 2). This is an 8-
fold shift in EC50 value relative to the positive control, and this shift was statistically 
significant (p < 0.007).   Overall, the hierarchy of crucial amino acid positions at Zone B 
for activation of xtMC2R based on EC50 values was : A10-14>A10/14>KP>P.  
D) ACTH(1-24) Zone B Truncated Analogs: cAMP  Assays 
The working hypothesis is that the Zone B motif is required for the proper 
positioning of the HFRW motif and the KKRRP motif of  ACTH(1-24) into 
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corresponding binding sites on the receptor.  The next experiments asked the question of 
whether analogs of ACTH(1-24) shortened in the Zone B motif can stimulate the 
receptor. The analogs, ACTH(1-21) and ACTH(1-22), were made to address this 
question. 
Figure 17:  Wild Type Xenopus tropicalis MC2R & Human ACTH Truncated 
Analogs 
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This figure represents a collection of activation curves based on cAMP production due to 
the stimulation of xt.MC2R with Zone B analogs of human ACTH(1-24). Dilutions of 
analogs ranged from 10
-6
-10
-12
 M. The positive control, xtMC2R was stimulated with 
hACTH(1-24) (red dots). The results of stimulating with ACTH(1-21) analog (blue 
squares) and ACTH(1-22) analog (green diamonds) are shown, N = 3.  
The first analog, ACTH(1-21) was shortened by removing amino acid positions 
11, 12, and 13 (Lysine-Proline-Valine) from Zone B (Table 2). The second analog, 
ACTH(1-22), was shortened by removing amino acid positions 10 and 14, which were 
glycine residues at positions 10 and 14 (Table 2). Figure 17 presents the results of 
stimulating xtMC2R with these truncated analogs. As indicated in the figure neither 
analog was able to stimulate the receptor at ligand concentrations ranging from 10
-12
M to 
10
-6
M (Table 2). Clearly, the length of ACTH(1-24) plays a role in the activation of the 
receptor.  
The results of the alanine analog studies have been used to create a proposed 
mechanism for the activation of xtMC2R. This model will be presented in the Discussion 
section.  
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Table 2: Human ACTH(1-24) Analog EC50 and P Values 
Analogs Amino Acid Sequence EC50 ± SEM 
(10
-9
 M) 
Fold 
Change 
P-Value 
ACTH(1-24) SYSMEHFRWGKPVGKKRRPVKVYP 7.23 ± 3.2 --- --- 
A4 SYSMEAAAAGKPVGKKRRPVKVYP NA --- --- 
AFRW SYSMEAFRWGKPVGKKRRPVKVYP NA --- --- 
HARW SYSMEHARWGKPVGKKRRPVKVYP NA --- --- 
HFAW SYSMEHFAWGKPVGKKRRPVKVYP NA --- --- 
HFRA SYSMEHFRAGKPVGKKRRPVKVYP NA --- --- 
A10-14 SYSMEHFRWAAAAAKKRRPVKVYP NA --- --- 
AKPVA SYSMEHFRWAKPVAKKRRPVKYVP 180 ± 61* 24.8 0.02 
GAAVG SYSMEHFRWGAAVGKKRRPVKVYP 310 ± 17*** 42.8 0.00003 
GKAVG SYSMEHFRWGKAVGKKRRPVKVYP 56 ± 12* 7.7 0.007 
ACTH(1-22) SYSMEHFRW-KPV-KKRRPVKVYP NA --- --- 
ACTH(1-21) SYSMEHFRWG---GKKRRPVKVYP NA --- --- 
A5 SYSMEHFRWGKPVGAAAAAVKVYP NA --- --- 
AARRP SYSMEHFRWGKPVGAARRPVKVYP 3700 ± 3900 511.7 0.2 
KKAAA SYSMEHFRWGKPVGKKAAAVKVYP 5000 ± 1400* 691.6 0.01 
***Human ACTH(1-24) Analog Zones = Zone A, Zone B, Zone C This table represents 
human ACTH(1-24) analogs in Zones A, B, and C. Each ligand is shown with its alanine 
substitution(s) at the respective position(s) while the wild type hACTH(1-24) is shown as 
the first ligand. It should be noted that the EC50 of the standard curve is a mean of all wild 
type ACTH(1-24) standard activation curves. Experimental EC50 values are reported, and 
were standardize at 10
-9
 Molar. If a ligand did not receive a calculated EC50 value, the 
ligand was reported as causing no activation (NA). The fold change of ACTH(1-24) 
analogs was reported for experimental EC50 values that were found to be  of significance. 
Fold change = (Experimental EC50 value ÷ Standard EC50 value). If the analog’s EC50 
value was found to be significantly different than the mean positive standard EC50 value, 
p-values were reported to suggest statistical significance (*: p-value < 0.05; **: p-value 
<0.005; ***: p-value < 0.0005). 
xtMC2R Alanine Mutant Studies: TM4, EC2, and TM5 Regions 
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As noted, there is general agreement that the HFRW binding site in all 
melanocortin receptors involved amino positions located close to the surface in TM 
regions 2, 3, 6, and 7 (Pogosheva et al. 2005; Baron et al. 2008; Dores, 2009; Dores, 
2013; Davis et al., 2013). The model presented in Figure 18 shows the relative position of 
HFRW binding site (TM regions in blue) and served as a reference point for the operating 
assumption that the KKRRP binding site would involve amino acid positions possibly in 
TM 4, extracellular loop 2 (EL2) or TM5.  
 
(Lisa Liang 2013 Ph.D. Thesis) On the “barrel” diagram the blue shaded areas indicate 
the location of the HFRW binding site, and the yellow shaded areas indicated the 
proposed location of the KKRRP binding site. In the linear diagram the positions that 
were targeted for alanine substitution are in color (red – TM2; green EL2; blue TM5).  
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In the initial experiments, all the amino acid positions in the respective colored 
regions (Figure 18; linear image of the receptor) were substituted with alanine residues. 
This resulted in three mutant receptors that were labeled X1 (TM4 mutant), X2 (EL2 
mutant), and X3 (TM5 mutant), respectively. These mutant receptors were individually 
stimulated with hACTH(1-24). In these experiments (Figure 19), the wild type xtMC2R 
(black circles) was also stimulated with hACTH(1-24) and served as the positive control. 
Stimulation of the X1 mutant receptor (TM4 region; blue squares) resulted in a significant 
decrease in cAMP production. The estimated EC50 value for this dose response curve was 
1.60 x 10
-7
M and resulted in a 168-fold shift in the EC50 value relative to the positive 
control (Table 3; p < 0.01).   The X2 mutant (EL2 region; green diamonds) did not show 
any signs of activation. Therefore, an EC50 value for this mutant receptor could not be 
calculated (Table 3). Stimulation of the X3 mutant receptor (TM5 region; red triangles) 
resulted in a slight production of cAMP. The X3 mutant receptor had an estimated EC50 
value of 3.7 x 10
-8
 M; a 34-fold shift in EC50 value as compared to the positive control 
(Table 2). Although these results were suggestive, the presence of so many alanine 
residues in each of these mutants could have altered confirmation, and as a result affected 
trafficking of the mutant receptor to the plasma membrane. Hence, the next approach was 
to do single alanine substitutions in each targeted region.     
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Figure 19: Xenopus Tropicalis MC2R TM4, EC2, and TM5 (X1, X2, and X3) Regions 
with Complete Alanine Substitutions  
 
This figure represents a collection of mutant xtMC2R activation curves with multiple 
alanine substitutions in the TM4, EL2, and TM5 regions of the receptor. The TM4, EL2, 
and TM5 were abbreviated as X1, X2, and X3 respectively. The X1, X2, and X3 mutant 
were all stimulated with hACTH(1-24). Dilutions of hormone ranged from 10
-6
-10
-12
 M. 
The wild type xtMC2R is shown in black circles. The X1 mutant receptor (TM4: blue 
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squares) had a deceased response to hormone stimulation, and the estimated EC50 value 
for this dose response curve was 1.6 x 10
-8
 M (Table 3). The X2 mutant receptor (EC2; 
green diamonds) did not show any activation. The X3 mutant receptor (TM5; red 
triangles) showed a slight activation at 10
-7
M and 10
-6
M. The estimated EC50 value for X3 
mutant receptor was 3.7 x 10
-8
 M (Table 3). 
A) Transmembrane 4 Domain (TM4): Single Alanine Mutant Assays 
          The activation dose response curves for the single alanine mutants of the TM4 
region are presented in Figures 20 and 21. The EC50 values and the fold shift in EC50 
values relative to the positive control for these single alanine mutant receptors are 
presented in Table 3. In Figure 20, the dose response curves for the single alanine 
mutants at amino acid positions G
171
, I
172
, and A
173
 are presented.  For the A
173 
mutant a 
glutamine residue was used.  All three receptors had EC50
 
values that were statistically 
different from the positive control (Table 3). However, there was only a threefold change 
for the G/A
171
 mutant, and this change is not considered significant. There was a 8 fold 
change for the I/A
172
 and this is a mild, but not dramatic shift in EC50. However, the 
A/Q
173
 mutant had a 55 fold shift in EC50 value, and this outcome was initially 
unexpected. Alanine substitution is the most common approach used in this type of study 
because alanine residues are generally considered to be place holder residues. The R-
group for this amino does not interact with other amino acid R-groups, hence we assumed 
this position would not be involved in the receptor activation process. However, by 
substituting a glutamine residue, an amino acid with a much larger and more reactive R-
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group, we suspect that we have interfered with the role that neighboring amino acids may 
play in the activation process.   
Figure 20: Xenopus Tropicalis TM4 Mutant Receptors G171, I172, & A173 
 
Dose response curves for G
171
, I
172
, and A
173
 mutants in the TM4 region of the receptor. 
The mutant receptors were all stimulated with hACTH(1-24) at dilutions ranging from 
10
-6
-10
-12
 M.  The dose response curve for the wild type xtMC2R is shown in red circles. 
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The dose response curves for the G
171
 mutant (blue squares), the I
172
 mutant (green 
diamonds), and the A
173
 mutant (black triangles) are presented. N = 3. 
Figure 21: Xenopus Tropicalis TM4 Mutant Receptors I174 & I175 
 
Dose response curves for the I
174
 and I
175
 mutants in the TM4 region of the receptor. The 
mutant receptors were all stimulated with hACTH(1-24) at dilutions ranging from 10
-6
-
10
-12
 M.  The dose response curve for the wild type xtMC2R is shown in red circles. The 
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dose response curves for the I
174
 mutant (blue squares) and the I
174
 mutant (green 
diamonds) are presented. N = 3. 
In Figure 21 the dose response curves for the single alanine mutants at amino acid 
positions I
174
 and I
175
 are presented. The EC50 values for this mutant receptor are 
presented in Table 3. The EC50 value for the I/A
174
 was only three fold and not considered 
significant. However, the I/A
175
 mutant had an EC50 value that resulted in a 284.2 fold 
shift relative to positive control. This amino acid position is clear important for the 
activation of xtMC2R. In addition it is possible that the A/Q
173
 mutant may have partially 
interfered with I
174
. 
B) Extracellular Loop 2 (EL2): Single Alanine Mutants Assays 
The activation dose response curves for the single alanine mutants of the EL2 region 
are presented in Figures 22, 23, 24, and 25. The EC50 values and the fold shift in EC50 
values relative to the positive control for these single alanine mutant receptors are 
presented in Table 3. 
In Figure 22 the dose response curves for the single alanine mutants at amino acid 
positions M
176
, L
177
, and T
181
 are presented. The EC50 values for the M
176
, L
177
, and T
181
 
mutants were not significantly different from the positive control (Table 3); hence these 
positions do not appear to be involved in the activation of the receptor.   
       In Figure 23 the dose response curves for the single alanine mutants at amino acid 
positions F
178
 and A
182
 are present. For the A
182
 mutant a glutamine residue replace A
182
. 
Activation of the F/A
178
 mutant was affected as a result of the alanine substitutions, there 
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was an 83 fold shift in the EC50 value (Table 3) as a result. Not only does the EC50 value 
indicate receptor insensitivity, the Vmax for F/A
178
 mutant indicates a significant decrease 
in cAMP production. In addition, the A/Q
182
 mutant also clearly interfered with the  
Figure 22: Xenopus Tropicalis EC2 Mutant Receptors T181, L177, and M176 
 
Dose response curves for the M
176
, L
177
, and T
181
 mutants in the EL2 region of the 
receptor. The mutant receptors were all stimulated with hACTH(1-24) at dilutions 
ranging from 10
-6
-10
-12
 M.  The dose response curve for the wild type xtMC2R is shown 
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in red circles. The dose response curves for the M
176
 mutant (black triangles), L
177
 (green 
diamond), and the T
181
 mutant (blue squares) are presented. N = 3. 
Figure 23: Xenopus Tropicalis EC2 Mutant Receptors A182 & F178 
 
Dose response curves for the F
178
 and A
182
 mutants in the EL2 region of the receptor. The 
mutant receptors were all stimulated with hACTH(1-24) at dilutions ranging from 10
-6
-
10
-12
 M.  The dose response curve for the wild type xtMC2R is shown in red circles. The 
dose response curves for the F
178
 mutant (green triangles) and the A
182
 mutant (blue 
squares) are presented. N = 3. 
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activation of the receptor. It is possible that substitution at this site may have affected 
either H
179
 or M
183
 (see Table 3). 
       In Figure 24 the dose response curves for the single alanine mutants at amino acid 
positions H
179
, D
180
, and I
184
 are presented. Substitution at H
179
 had a minimal impact on 
the activation of the receptor (Table 3).  However, the dose response curve for the D/A
180
 
mutant resulted in an EC50 value with a 40 fold shift relative to the positive control (Table 
3). The dose response curve for the I/A
184
 mutant was even more dramatic. This mutant 
had an EC50 value with 495 fold shift relative to the positive control (Table 3). The I
184
 
position is clearly the most important site for interaction with the KKRRP region of 
ACTH(1-24).   
          In Figure 25 the dose response curves for the single alanine mutants at amino acid 
positions M
183
 and I
185
 are presented. The I/A
185
 mutant generated a dose response curve 
with an EC50 value that resulted in a 2 fold shift relative to the positive control (Table 3). 
Substitution at this site does not appear to significantly affect the activation of the 
receptor. However, the M/A
183 
mutant generated a dose response curve with an EC50 
value that resulted in a 22 fold shift relative to the control (Table 1), and this position is 
considered important for the activation of the receptor. 
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Figure 24: Xenopus Tropicalis EC2 Mutant Receptors H179, I184, & D180 
 
Dose response curves for the H
179
, D
180
, and I
184
 mutants in the EL2 region of the 
receptor. The mutant receptors were all stimulated with hACTH(1-24) at dilutions 
ranging from 10
-6
-10
-12
 M.  The dose response curve for the wild type xtMC2R is shown 
in red circles. The dose response curves for the H
179
 mutant (blue squares), D
180
 (black 
squares), and the I
184
 mutant (green squares) are presented. N = 3. 
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Figure 25: Xenopus Tropicalis EC2 Mutant Receptors M183 & I185 
 
Dose response curves for the M
183
 and I
185
 mutants in the EL2 region of the receptor. The 
mutant receptors were all stimulated with hACTH(1-24) at dilutions ranging from 10
-6
-
10
-12
 M.  The dose response curve for the wild type xtMC2R is shown in red circles. The 
dose response curves for the M
183
 mutant (blue squares) and the I
185
 mutant (green 
diamonds) are presented. N = 3. 
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C) Transmembrane 5 Domain: Single Alanine Mutant Assays 
The activation dose response curves for the single alanine mutants of the TM5 region 
are presented in Figures 26, 27, and 28. The EC50 values and the fold shift in EC50 values 
relative to the positive control for these single alanine mutant receptors are presented in 
Table 3. In Figure 26 the dose response curves for the C
186
 and L
187
 mutants are 
presented. In Figure 27 the dose response curves for the T
188
, V
189
, and M
190
 mutants are 
presented. In Figure 28 the dose response curves for the F
191
 and L
192
 mutants are 
presented. As indicated in Table 3, none of these mutants had dose response curves with 
EC50 values greater that 4 fold relative to the positive control with the exception of L/A
187
 
mutant (6.5 fold change). Based on these observations it appears that region of the 
receptor is not important for the activation of the receptor.  
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Figure 26: Xenopus Tropicalis TM5 Mutant Receptors C186 & L187 
 
Dose response curves for the C
186
 and L
187
 mutants in the TM5 region of the receptor. 
The mutant receptors were all stimulated with hACTH(1-24) at dilutions ranging from 
10
-6
-10
-12
 M.  The dose response curve for the wild type xtMC2R is shown in red circles. 
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The dose response curves for the C
186
 mutant (blue squares) and the L
187
 mutant (green 
diamonds) are presented. N = 3. 
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Figure 27: Xenopus Tropicalis TM5 Mutant Receptors T188, V189 & M190  
 
Dose response curves for the T
188
, V
189
, and M
190
 mutants in the TM5 region of the 
receptor. The mutant receptors were all stimulated with hACTH(1-24) at dilutions 
ranging from 10
-6
-10
-12
 M.  The dose response curve for the wild type xtMC2R is shown 
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in red circles. The dose response curves for the T
188
 mutant (blue squares), V
189
 mutant 
(green diamonds), and the M
190
 mutant (black squares) are presented. N = 3. 
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Figure 28: Xenopus Tropicalis TM5 Mutant Receptors F191 & L192 
 
Dose response curves for the F
191
 and L
192
 mutants in the TM5 region of the receptor. 
The mutant receptors were all stimulated with hACTH(1-24) at dilutions ranging from 
10
-6
-10
-12
 M.  The dose response curve for the wild type xtMC2R is shown in red circles. 
The dose response curves for the F
191
 mutant (blue squares) and L
192
 mutant (green 
diamonds), are presented. N = 3. 
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Table 3:  Xenopus tropicalis TM4, EC2, and TM5 Mutant Receptor EC50 Value and 
P-Values 
Amino Acid EC50  (10
-9M) Fold Change P-Value 
Wild Type 0.95 ± 0.44 --- --- 
X1 160 ± 49* 168.4 0.01 
X2 NA --- --- 
X3 37 ± 29  34 0.1 
G171 2.8  ± 0.62** 3.0 0.0008 
I172 8.3 ± 0.31*** 8.7 0.00008 
A173 52.4 ± 4.76*** 55.2 0.0002 
I174 2.8 ± 0.66** 3.0 0.001 
I175 270.0 ± 72*** 284.2 0.0002 
M176 0.8 ± 0.09 0.8 0.8 
L177 0.98 ± 0.11 1.0 0.4 
F178 79.0 ± 14*** 83.2 0.00004 
H179 2.9 ± 0.87** 3.1 0.002 
D180 38.0 ± 8.6*** 40 0.0001 
T181 0.72 ± 0.17 0.7 0.9 
A182 14.0 ± 1.1*** 14.7 0.0002 
M183 22.0 ± 1.8*** 23.2 0.0002 
I184 470.0 ± 240** 494.7 0.002 
I185 2.0 ± 0.93* 2.1 0.02 
C186 3.5 ± 1.1** 3.7 0.001 
L187 6.2 ± 1.04*** 6.5 0.00008 
T188 0.5 ± 0.07 0.5 0.9 
V189 2.4 ± 1.4* 2.5 0.02 
M190 2.2 ± 0.44** 2.3 0.002 
F191 1.62 ± 0.42* 1.1 0.01 
L192 0.75 ± 0.3 0.8 0.8 
This table includes all EC50 values for the xt.MC2R TM4, EC2, and TM5 region mutant 
receptors where single alanines substituted corresponding amino acid positions of the 
xt.MC2R. Also, the EC50 for complete alanine substitution of TM4, EC2, and TM5 
regions were inserted at the top of the table. The fold change of the mutant receptors 
compared to the mean EC50 value of the standard curve was calculated as Fold Change = 
mutant receptor EC50 value ÷ standard EC50 value. Also, a Student’s T Test was used to 
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observe if mutant receptor EC50 value was different than standard EC50 value. If the 
comparison of the two EC50 values differed drastically, the mutant receptor would be 
designated as significant. Therefore, significance would of the experimental EC50 value 
would be assigned a p-value ≤ 0.05 (*: p-value < 0.05; **: p-value < 0.005; ***: p-value 
< 0.005) 
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Discussion 
Tetrapod and Teleost MC2Rs: MRAP1 Requirement and Ligand Selectivity for ACTH 
This study on the melanocortin-2 receptor of the amphibian, Xenopus tropicalis 
(xtMC2R), adds to the growing literature on teleost and tetrapod MC2Rs, and provides 
additional evidence that among teleost and tetrapod MC2Rs there are a number of 
universal features.  First, teleost and tetrapod MC2Rs can only be activated by ACTH 
(for review see Dores, 2013). In this regard, only the ACTH(1-24) sequence is required 
for full activation of teleost or tetrapod MC2R. Second, teleost and tetrapod MC2Rs 
require an intimate interaction with MRAP1 in order to not only move from the ER to the 
plasma membrane, but also for activation following an ACTH binding event. The 
corollary to this statement is that it appears that tetrapod MC2Rs require interaction with 
tetrapod MRAP1, and teleost MC2Rs require interaction with a teleost MRAP1 to 
achieve functional activation (Liang et al., 2011).   
With regard to the MC2R expression requirements, the results of this study 
showed that xtMC2R cannot be functionally expressed without interaction with a 
mammalian MRAP, (i.e., mouse MRAP1; Figure 12). Although it is hypothesized that an 
xtMRAP1 homolog exists in the Xenopus tropicalis genome, this accessory protein gene 
has yet to be identified. Therefore for the studies presented in this thesis, mouse MRAP1 
(mMRAP1) was used to functionally express xtMC2R on the plasma membrane of CHO 
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cells.  However, genomic screening has detected a homolog of the MRAP2 gene in the X. 
tropicalis genome. Past studies have shown that xtMC2R can be activated by xtMRAP2 
in the CHO cell functional assay system. However, activation was only shown at the 
highest concentration of  hACTH(1-24) tested (i.e., 10
-6
M;  Liang et al., 2011). Similar 
results were observed in Figure 12 when an ortholog of MRAP2 (mMRAP2) was co-
expressed with xtMC2R.  
With regard to ligand selectivity, several studies have shown that mammalian 
MC2Rs cannot be activated by α-MSH ((Buckley and Ramachandran, 1981; Mountjoy et 
al.,1992; Schwyzer,1997). As previously noted, the α-MSH amino acid sequence is 
positioned within the ACTH(1-39) amino acid sequence (Figure 4B). This thesis showed 
that while xtMC2R can be activated by ACTH(1-24) (Figure 13), this receptor cannot be 
activated by α-MSH (Figure 13). Given the sequence relationship between α-MSH and 
ACTH, these observations support the hypothesis that tetrapod MC2Rs interact not only 
with the HFRW motif in ACTH. But also with another site in ACTH (Schwyzer, 1977), 
and correspondingly, the melanocortin-2 receptor must have multiple binding sites for 
ACTH. In support of these conclusions a recent study indicated that the MC2R ortholog 
of the  reptile, Anolis carolinensis, also required co-expression with mMRAP1 when 
expressed in CHO cells, and the reptile receptor could be activated by ACTH(1-24), but 
not by α-MSH (Davis et al., 2013).  
The arguments for expanding the ligand selectivity and MRAP1 requirements of 
MC2R to include teleost MC2Rs, come from studies on the zebrafish, Danio rerio 
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(Agulleiro et al., 2010), the rainbow trout, Oncorhynchus mykiss (Aluru and Vijayan, 
2008; Liang et al., 2011), and the sea bass, Dicentrarchus labrax , (Aquilleiro et al., 
2013).  In these studies, the functional expression of the teleost MC2R in heterologous 
mammalian cell lines required co-expression with a teleost MRAP1. In addition, ligand 
selectivity studies confirmed that while the teleost MC2Rs could be activated by 
hACTH(1-24), these melanocortin receptors did not respond to stimulation by α-MSH. 
Hence, it appears that among the bony vertebrates (i.e., modern bony fishes, amphibians, 
reptiles, birds, and mammals), MC2R is MRAP1 dependent, and insensitive to α-MSH. 
These conclusions are summarized in Figure 29.  
Do these conclusions apply to all gnathostomes? The cartilaginous fishes, 
together with the bony vertebrates constitute Superclass Gnathostoma (Nelson, 1994). 
Recently an ortholog of MC2R has been detected in the genome of the cartilaginous fish, 
Callorhinchus milii (the elephant shark; Vastermark and Schioth, 2011). Studies on the 
elephant shark MC2R indicate that this receptor is MRAP1 independent and the receptor 
can be activated by both ACTH(1-24) and α-MSH (Reinick et al., 2012). Similar results 
have been observed for the MC2R ortholog in the genome of the sting ray, Dasyatis 
akajei  (R.M. Dores, unpublished data).  
Collectively, these observations have led to the following evolutionary hypothesis 
(Figure 29; Dores, 2013). During the emergence of the ancestral gnathostomes 
(approximately 480 MYA), the melanocortin-2 receptor was MRAP1 independent, and 
the receptor could be activated by both ACTH and α-MSH. These properties appear to be 
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retained in the cartilaginous fishes. Following the divergence of the ancestral 
cartilaginous fishes, and the ancestral bony fishes, mutations occurred in the MC2R gene 
in the bony fish lineage. These mutations resulted in the exclusive selectivity of MC2R 
for ACTH, but these changes also led to the dependence on MRAP1 for the functional 
expression of MC2R. The ramifications of these mutations will be discussed in a later 
section of this Discussion.   
Figure 29: Phylogeny of MC2R Ligand Selectivity and Interaction with MRAP  
Cartilaginous                   Bony                Anamniote   Amniote
Fish                              Fish Tetrapods             Tetrapods
MC2R/ MRAP
MC2R/ACTH
MC2R: MRAP dependent 
MC2R: MRAP independent 
MC2R: ACTH only
MC2R: ACTH or αMSH
 
Tetrapod and Teleost ACTH(1-24) Analog Studies 
 Prior studies have shown that ACTH(1-24) is the functional region of ACTH(1-
39). These studies had also proposed that this functional region consists of two motifs 
that are essential for the activation of mammalian MC2R: the HFRW motif and KKRRP 
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motif (Eberle and Schwyzer, 1975; Schwyzer, 1977).  Do these same requirements apply 
to other tetrapod MC2Rs such as X. tropicalis MC2R? Would these same requirements 
apply to a teleost MC2R? To address these questions this thesis analyzed the effect of 
introducing alanine substitutions into hACTH(1-24), and testing the effects of these 
analogs on the functional activation of xtMC2R. Another thesis project (Lisa Liang, 
2013) conducted a parallel study on rainbow trout MC2R. The analogs that were tested 
were divided into three zone (A, B, C) as shown in the Methods (Table 1), which 
corresponded to the H
6
F
7
R
8
W
9
 motif, the G
10
K
11
P
12
V
13
G
14
 motif, and the 
K
15
K
16
R
17
R
18
P
19
 motif, respectively.  
Before discussing the results of the Zone A (HFRW) analog studies, it should be 
noted that all melanocortin peptides have the HFRW motif (Schwyzer, 1977), and 
conversely, the activation of all melanocortin receptors is dependent on the binding of 
this motif on the ligand to the receptor. Is there a common HFRW binding site on all 
melanocortin receptors?  Pogosheva et al (2005) initially addressed this question by 
performing a modeling study and site directed mutagenesis study on the human 
melanocortin-4 receptor (hMC4R). That study identified critical amino acid positions in 
TM 2, 3, 6, and 7 that are required for interacting with the HFRW motif of α-MSH. 
Those amino acid positions are shown in Figure 30A. Interestingly these same positions 
are nearly universally conserved in the MC1R, MC3R, MC4R, and MC5R paralogs of 
teleosts and tetrapods (Dores, 2009; Baron et al., 2009). Does xtMC2R have these critical 
positions? As shown in Figure 30B, nine of the twelve critical amino acid positions are 
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identical in xtMC2R and hMC4R. If the analysis is expanded to include human MC2R 
and rainbow trout MC2R, six of the positions are identical in all four sequences.  
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Analysis of Zone A Analogs of hACTH(1-24)  
As presented in the Results, there were five Zone A analog (HFRW analogs): A4 
(AAAA), AFRW, HARW, HFAW, and HFRA. As expected, the A4 analog was unable 
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to stimulate activation at any concentration tested. These results were not surprising. 
However, it was unclear at the start of these experiments how single alanine substitutions 
would affect the activity of the Zone A analogs. Initially the analogs were tested on the 
hMC4R expressed in CHO cells (Liang et al., 2013). For hMC4R, the order of 
importance of the amino acid positions in the HFRW motif was W>>R=F>H. 
Substitution at the W
9
 completed blocked stimulation of hMC4R, whereas substitution at 
ether F
7
or R
8
 shifted the EC50 value 15,000 fold relative to the positive control, and 
substitution at the H
6
 resulted in 100 fold shift in EC50 value relative to the control. When 
these same analogs were tested on human MC2R, the order of ligand importance was 
W>>F>R>H (Liang et al., 2013). Once again substitution at W
9
 completely blocked 
activation of hMC2R. However, substitutions at F
7
, R
8
, and H
6
 resulted in shifts in EC50 
values of 8000 fold, 4000 fold, and 9 fold respective.  Clearly, hMC4R and hMC2R did 
not respond to the Zone A analogs to the same degree. While the W
9
 position is clearly 
essential for both receptors, substitution at the other positions produced receptor-specific 
responses. These outcomes can be partially explained by the subtle differences in primary 
sequence at HFRW binding sites of the two receptors (Figure 29).  
When these same single alanine Zone A analogs were tested on xtMC2R,  there 
was no activation of the receptor following incubation with either the HARW analog or 
the HFRA  analog  (Table 2). In addition, only slight activation was observed at a 
concentration of 10
-6
 M following incubation with the HFAW analog and AFRW analog 
(W=F>>R=H).  Clearly primary sequence differences at the critical positions in the 
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HFRW binding site (Figure 30) appear to make xtMC2R much less tolerant of alanine 
substitutions to hACTH(1-24) than hMC2R. It would be reasonable to speculate that the 
3-dimensional shape of the HFRW binding site in xtMC2R and hMC2R may be similar, 
but definitely not identical.   
When these same single alanine Zone A analogs were used to stimulate the 
rainbow trout MC2R (rtMC2R), yet another pattern was observed with the respect the 
order amino acid position importance. For rtMC2R the order was W=R>F>H (Lisa 
Liang, Ph.D. thesis, 2013). For the rtMC2R, incubation with the HFRA analog actually 
resulted in a dose dependent stimulation at 10
-7
M and 10
-6
M. This level of stimulation 
was not observed for hMC2R, hMC4R, or xtMC2R. In addition, substitution at H
6
 had no 
negative effect on activation; the EC50 value for the AFRW analog was not statistically 
different from the positive control (Lisa Liang, Ph.D. thesis, 2013). Collectively, these 
observations lend support to the conclusion that while an HFRW binding site is a 
common feature of all melanocortin receptors, there appears to be differences in the 3-
dimension structure of this site even between orthologs. Molecular modeling approaches 
are needed to resolve these shape differences.  
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Analysis of Zone C Analogs of hACTH(1-24)  
The role of the KKRRP motif (Zone C) in ACTH(1-24) as the “address” motif 
required for initial interaction with the “ACTH” receptor (aka MC2R) was initially 
proposed by Schwyzer (1977). Analogs of this region included A5 (A
15
A
16
A
17
A
18
A
19
), 
A
15
A
16
RRP, and KKA
17
A
18
A
19
. As shown in Figure 15 there was no stimulation of 
xtMC2R following incubation with the A5 analog at any of the concentrations tested. The 
same outcome was observed when the A5 analog was tested on rtMC2R (Lisa Liang, 
Ph.D. Thesis, 2013). However, incubation of the hMC2R with the A5 analog resulted in a 
dose dependent increase in cAMP production at concentrations of 10
-8
M and 10
-7
M.  
In addition, incubation of xtMC2R with the analogs, AARRP and KKAAA, 
resulted in diminished activation of xtMC2R, and the EC50 values for these analogs were 
5.0 x10
-6
 M and 3.7 x 10
-6 
M, respectively (Table 2). The rtMC2R show a similar 
response to these analogs (Lisa Liang, Ph.D. Thesis, 2013). For xtMC2R and rtMC2R it 
appears that the interaction with positions 15 and 16 in the KKRRP motif might be more 
important for activation than interaction at positions 17, 18, and 19. Just the opposite was 
observed for hMC2R (Liang et al., 2013).  
Figure 31: Amino Acid Sequences of ACTH in Multiple Species 
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Analysis of Zone B Analogs of hACTH(1-24)  
       It is surprising that since the studies by Schwyzer and colleagues on ACTH truncated 
analogs (Schwyzer, 1977), no analog studies have been done on the GKRVG (Zone B) 
motif of ACTH until recent thesis projects in our lab. The rationale for these experiments 
was that the GKRVG motif has been conserved in vertebrate evolution because this motif 
serves as “linker” region between the HFRW motif and KKRRP motif to properly 
position these motifs on the surface of MC2R so that the activation event can proceed 
(Liang et al., 2013). The results of the alanine substitution experiments on xtMC2R, 
hMC2R, and rtMC2R support this assumption. As shown for xtMC2R in Table 2, either 
single alanine substitution or double alanine substitution in this region of the ligand 
affected the EC50 value in a negative manner.  However, the most compelling argument 
for the importance of the GKPVG motif came from the truncation experiments. When the 
hACTH(1-24) sequence was shortened to the ACTH(1-21) or the ACTH(1-22) analog 
(Table 1) there was a complete lack of stimulation of, not only xtMC2R (Table 2), but 
also hMC2R and rtMC2R (Lisa Liang, Ph.D. thesis). Collectively, the results from the 
alanine substitution and the shortened Zone B ligand experiments underscore the 
importance of the secondary structure of Zone B (GKPVG), and suggest that this motif 
may play a crucial role in positioning the HFRW and KKRRP motifs, so that proper 
interaction of the ligand and receptor could occur to result in activation of the MC2Rs. 
These observations have led to the following hypothesis to account for the activation of 
tetrapod and teleost MC2Rs (Figure 32). This mechanism requires that tetrapod and 
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teleost MC2Rs interact with the MRAP1 homodimer at the rough endoplasmic reticulum. 
In the absence of MRAP1 the receptor will miss-fold and be degraded by the protein 
quality control mechanism in the endoplasmic reticulum (Hinkle and Sebag, 2010).   
Figure 32A: Proposed Model of MC2R Activation 
 
As shown in Figure 32A, MC2R is positioned on the plasma membrane, in 
contact with MRAP1, and in a “pre-activation” state. Based on the ligand and analog 
studies we assume that there are two binding sites on the receptor. The KKRRP binding 
site is exposed, but the HFRW binding site is not accessible in the pre-activation state. As 
a result in the pre-activation state, α-MSH cannot activate the receptor. However, as 
shown in Figure 32B, when ACTH(1-24) makes contact with the receptor, the KKRRP 
motif on ACTH(1-24) can interact with the exposed KKRRP binding site on the receptor. 
KKRRP
HFRW
In the Presence of MRAP1 At the Plasma Membrane
Pre-activation State
SYSMEHFRWGKPV
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This event would be Step 1 of the activation process. The argument to support the Step 1 
event comes from the observations by Lisa Liang (Ph.D thesis) that the analog ACTH(15-
24) blocks the binding of ACTH(1-24) to the receptor and inhibits activation as a result. 
Figure 32B: Proposed Model of MC2R Activation 
 
For this proposed mechanism, the prediction is that the docking at the KKRRP 
binding site results in a conformation change in the receptor (Figure 32C). This 
conformation change exposes the HFRW binding site. This is Step 2 of the activation 
process. Because of the “linker” role that the GKPVG motif plays, the HFRW motif in 
the ligand is properly positioned to interact with the exposed HFRW binding site on the 
receptor. The later interaction is predicted to induce another conformational change in the 
KKRRP
HFRW
In the Presence of MRAP1 At the Plasma Membrane
Pre-activation State
SYSMEHFRWGKPVGKKRRPVKVYP
Activation Step 1 – bind to KKRRP binding site 
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receptor (Step 3) which results in the activation of the G protein and induces the 
subsequent biological response within the target cell.   
Figure 32C: Proposed Model of MC2R Activation 
   
         Based on this model, and given the slightly different responses to the Zone A, B, 
and C analogs observed for xtMC2R, hMC2R, and rtMC2R it would appear that 
difference in primary sequence (Figure 30) could contribute to subtle changes in the 3-
dimensional shape of these receptors. Confirmation of this conclusion will depend on 
molecular 3-dimensional modeling of the tetrapod and teleost MC2Rs.  
  
 
 
SYSMEHFRWGKPVGKKRRPVKVYP
Activation Step 2 – exposure of HFRW binding site 
HFRW K
KR
RP
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Tetrapod and Teleost MC2Rs: Mutant Receptor Studies – the KKRRP site on MC2R 
 As introduced in the preceding section, there is an extensive literature on the 
binding and signaling by α-MSH for mammalian MC1R, MC3R, and MC4R (Yang et al., 
2000; Chen et al., 2006). Furthermore, the study by Pogozheva et al. (2005) identified the 
HFRW binding site which is common to all melanocortin receptors including the MC2 
receptor. Table 4 (Liang, 2013) summarized the comparison between hMC4R, hMC2R, 
xtMC2R and rtMC2R in support of the assumption that all melanocortin receptors have a 
common HFRW binding site.  
Table 4: Proposed HFRW binding sites in MC4R and the corresponding residues of 
MC2R 
 
Although a high level of sequence similarity was found for the proposed HFRW 
binding sites on melanocortin receptors, there is still the question of where the docking 
site for the R/KKRRP is located within the melanocortin 2 receptor sequence. Working 
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from the model presented in Figure 33, this thesis focused on the TM 4, extracellular loop 
2 (EL2), and the TM5 regions of xtMC2R.  
Figure 33: 3-Dimensional Diagram of the MC2R binding sites for the HFRW and 
R/KKRRP motifs 
 
The single alanine substitution experiments for xtMC2R are summarized in 
Figure 34A. There were nine residues in TM4, EL2, and TM5 that appear to be 
important, from a statistical perspective, for the activation of xtMC2R by hACTH(1-24) 
(see Table 3).  However, as noted in the Results section, the alanine mutants that resulted 
in at least a 10 fold shift in EC50 values, relative to the positive control, were: A
173
, I
175
, 
F
178
, D
180
, A
182, 
M
183
, and I
184
. Since the A
173
 and A
182 
 sites are considered intrinsically 
inert in the wild-type receptor, we feel that the substitution of a glutamine residue at these 
two positions most likely disrupted natural interactions between the ligand and the 
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receptor. Hence, the critical sites for facilitating activation of xtMC2R are:  I
175
, F
178
, 
D
180
, 
, 
M
183
, and I
184
.  Among these positions a 50 fold or greater shift in EC50 values was 
observed for I
175
, F
178
, and I
183
, and a 100 fold or greater shift in EC50 values was 
observed for the I/A
175
 mutant and the I/A
183
 mutant. It would appear then that positions 
I
175
, F
178
, and I
183
  are the most important for activation of xtMC2R following the ligand 
binding event (Step1; Figure 33). 
Recently, single alanine substitutions were performed on the TM4, EL2, and TM5 
regions of hMC2R and rtMC2R (Lisa Liang, Ph.D. thesis, 2013). For hMC2R and 
rtMC2R a set of amino acid positions were also identified in these regions that affected 
EC50 values by at least 10 fold (Figure 34C). While the model presented in Figure 33 
targets TM4, EL2, and TM5 as the most likely location for the KKRRP docking site, a 
comparison of the primary sequences of xtMC2R, hMC2R, and rtMC2R resulted in a 
number of surprising observations (Figure 34B).  
The underlined residues in Figure 34B were the amino acids positions that were 
targeted for single alanine or glutamine replacement. For TM4 and TM5 site directed 
mutagenesis was performed on the seven amino acid positions closest to the extracellular 
space. The rationale for selecting these positions was that Pogosheva et al. (2005) 
observed that the amino acid positions involved for the HFRW binding site are located 
within seven residues of the surface of the cell. Hence, it seemed reasonable to predict 
that the hydrophilic pocket for the KKRRP docking site would also be relatively close to 
the surface of the cell. The feature that is striking about Figure 34B is that the alignment 
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of the sequences of xtMC2R, hMC2R, and rtMC2R indicated that within the underlined 
zone only three positions are identical in the three receptors (residues in red).  An 
additional eight positions (pink) have amino acids in the same group (i.e., hydrophobic, 
polar uncharged, or polar same charge). Hence, the striking feature is the lack of primary 
sequence identity in this region of the three receptors.  
       In terms of functionality, the critical positions in xtMC2R that have at least a 10 fold 
influence on EC50 value are located within TM4 and EL2 (Figure 34C), and the positions 
in this receptor that have a 100 fold or greater effect on  EC50 value were located in TM4 
and EL2. Note that positions in TM5 do not appear to be essential for the activation of 
xtMC2R. When the same comparison is done for hMC2R, the positions with at least a 10 
fold influence on EC50 value are located in EL2 and TM5, the position in hMC2R that 
had a 100 fold or greater effect on EC50 value was restricted to a single position in TM5. 
Note the apparent absence of a role for TM4 in the activation of hMC2R. These 
observations are in contrast to rtMCR2 where the positions that had at least a 10 fold or 
100 fold influence on EC50 value are located within TM4 and TM5. Note that for 
rtMC2R, the EL2 region does not appear to be important for the activation of the 
receptor. Collectively these observations indicate that while the TM4/EL2/TM5 region of 
these MC2Rs appears to be the target for the docking of the KKRRP motif of ACTH; the 
primary sequence of this zone in the three receptors do not provide a simple explanation 
for where the KKRRP docking event (Step 1) will occur. The prediction would be that 
the 3-dimensional shape of the TM4/EL2/TM5 region must be similar in all three 
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receptors. Another prediction is that the interaction between the KKRRP motif of ACTH 
and the corresponding docking site on the receptor relies upon hydrogen bonding and 
hydrophobic interactions between the R-groups rather than ionic interactions (note the 
absence of acidic amino acids in this region with the exception of the lone aspartic acid 
reside (D) in EL2 of xtMC2R. At this stage, it would difficult to obtain further 
information from additional site-directed mutagenesis experiments. The next step should 
be to do molecular 3-dimensional modeling of these receptors.          
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Figure 34: Tetrapod/Teleost Comparison of MC2R Single Alanine Substitutions 
A. xMC2R: Summary of single alanine substitution 
   
      [--------TM4---------]   EL2   [-------TM5---------] 
xMC2R RASVILAVIWTFCGGSGIAIIMLFHDTAMIICLTVMFLLLLVLIVCLYIHMF 
 
B. Sequence identity in TM4,EL2,and TM5 of hMC2R,xMC2R and 
rtMC2R  
  
      [--------TM4---------]   ELC2   [-------TM5---------] 
xMC2R RASVILAVIWTFCGGSGIAIIMLFHDTAMIICLTVMFLLLLVLIVCLYIHMF 
hMC2R RTVVVLTVIWTFCTGTGITMVIFSHHVPTVITFTSLFPLMLVFILCLYVHMF   
rMC2R RAAAALAGIWALCGVAGAVMVAFCDATVIKIFFIVLFLISLLLILFLYVHMF 
 
C. Mutations that resulted in a 10 fold or greater shift in 
EC50 
 
      [--------TM4---------]   EL2   [-------TM5---------] 
xMC2R RASVILAVIWTFCGGSGIAIIMLFHDTAMIICLTVMFLLLLVLIVCLYIHMF 
hMC2R RTVVVLTVIWTFCTGTGITMVIFSHHVPTVITFTSLFPLMLVFILCLYVHMF   
rMC2R RAAAALAGIWALCGVAGAVMVAFCDATVIKIFFIVLFLISLLLILFLYVHMF 
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D. Mutations that resulted in a 100 fold or greater shift 
in EC50 
 
      [--------TM4---------]   EC2   [-------TM5---------] 
xMC2R RASVILAVIWTFCGGSGIAIIMLFHDTAMIICLTVMFLLLLVLIVCLYIHMF 
hMC2R RTVVVLTVIWTFCTGTGITMVIFSHHVPTVITFTSLFPLMLVFILCLYVHMF   
rMC2R RAAAALAGIWALCGVAGAVMVAFCDATVIKIFFIVLFLISLLLILFLYVHMF 
 
Final Observations 
   Based on the observations made in this thesis, xtMC2R has several basic properties 
that are identical to mammalian MC2Rs. It appears that all of the tetrapod MC2Rs can 
only be activated by ACTH, but not by any MSH-sized melanocortin ligand. In addition, 
all of the tetrapod MC2Rs require interaction with MRAP1 to facilitate functional 
activation of the receptor at the plasma membrane following stimulation with ACTH 
(Gantz and Fong, 2003; Hinkle and Sebag, 2009; Webb and Clark, 2010). This thesis has 
examined the effects of alanine substitutions in the functional zones of hACTH(1-24) 
(Table1). The operating assumption was that there would be a differential response of 
amniote MC2Rs (e.g. human) to these analogs of hACTH(1-24) as compared to the 
response of an anamniote MC2R (i.e., frog) to the same analogs. However, the outcome 
of this analysis did not neatly follow this simple dichotomy of the tetrapod MC2R 
sequences.   
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       The analysis of alanine-substituted analogs of the H
6
F
7
R
8
W
9
 motif of hACTH(1-24) 
indicated that xtMC2R could not tolerate any single alanine substitution in this motif 
(Davis et al., 2013). By contrast, human MC2R could tolerate some alanine substitutions 
in the H
6
F
7
R
8
W
9
 motif (Liang et al., 2013).  These observations may indicate subtle 
differences in the 3-dimensional structure of the HFRW binding sites of tetrapod MC2Rs. 
        Similar results were observed when the alanine substituted analogs of the 
K
15
K
16
R
17
R
18
P
19
 motif of hACTH(1-24) were analyzed. For xtMC2R it appears that 
positions 15 and 16 in the ligand are far more important for activation of the receptor 
(Table 2) than positions 17, 18, and 19 (Davis et al., 2013); whereas, for human MC2R, 
positions 17, 18, and 19 are clearly more essential for activation of the receptor (Liang et 
al., 2013). Figure 34 shows the proposed location of the putative KKRRP binding in 
MC2Rs. Given the lack of primary sequence identity in this region, secondary and 
tertiary structures at this proposed docking site would appear to be the critical factors for 
mediating the activation of these receptors.   
       The analysis of the G
10
K
11
R
12
V
13
G
14
 motif in hACTH(1-24) provided further 
evidence for the importance of this region of the ligand for activation of the receptor. 
These observations also may explain the nearly universal conservation of this motif in 
gnathostome ACTH sequences (Dores and Lecaude, 2005). With respect to the alanine 
analogs of the GKPVG motif, the response of hMC2R (Liang et al, 2013) was distinct 
from the response of xtMC2R (Table 2). In addition, the analysis of the ACTH(1-21) and 
the ACTH(1-22) analogs do point to the importance of the spatial positioning of the 
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HFRW binding site and the putative KKRRP binding site in tetrapod MC2Rs with 
respect to the proposed 3 step mechanism for the activation of the receptor (Figure 32). 
       When these observations are viewed collectively, the response of xtMC2R to these 
ACTH(1-24) analogs was subtly different than the response of hMC2R to these same 
analogs. It is possible that mammalian MC2Rs have evolved structural features distinct 
from the non-mammalian MC2Rs. At present, the data set is small and the 
generalizations should be viewed conservatively until modeling of the 3-dimensional 
shape of these receptors has been done.      
      That said, the additional structure/function data provided in this thesis add to the 
growing literature on the distinctive features of melanocortin-2 receptor orthologs in 
teleosts and tetrapods (Agullerio et al., 201; Liang et al., 2011). In this regard, the 
exclusive selectivity for ACTH and the requirement for interaction with an MRAP1 
ortholog are the two features which unite teleost and tetrapod MC2 receptor orthologs. 
The dependence of both teleost and tetrapod MC2Rs on MRAP1 for functional activation 
raises the question of whether there is an ortholog of MC2R that is MRAP independent. 
As noted in the Introduction, an MC2R ortholog detected in the genome of the 
cartilaginous fish, Callorhinchus milii [48], indicates that the C. milii MC2 receptor 
ortholog is MRAP independent. These observations would suggest that in the early 
evolution of the gnathostomes a MC2R-like receptor and a MRAP-like accessory protein 
functioned independent of each other. In this scenario following the divergence of the 
ancestral cartilaginous fish and the ancestral bony fish lineages, an interaction developed 
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between MC2R and MRAP1 that initially may have been neutral from a fitness 
perspective. However, as point mutations accumulated in the ancestral bony fish MC2R 
ortholog, the interaction with MRAP1 became essential for the functional activation of 
the receptor. The rescue of a misfolded MC2R by MRAP1 may have been a critical event 
during the early evolution of the bony fishes. Hence, the co-evolution of the MC2R gene 
and the MRAP1 gene appears to have been an important event in the evolution of the 
bony vertebrates (i.e., bony fishes, amphibians, reptiles, birds, and mammals.      
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